# EDGAR Filing Document

**Accession Number:** 0001657573
**File Stem:** 0001193125-25-264651
**Filing Date:** 2025-11
**Character Count:** 200172
**Document Hash:** c020e44dffe9c1c64922c24f63b617b2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-264651.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0001193125-25-264651

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 68

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xometry, Inc.
- **CENTRAL INDEX KEY:** 0001657573
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 320415449
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40546
- **FILM NUMBER:** 251448952

**BUSINESS ADDRESS:**
- **STREET 1:** 6116 EXECUTIVE BOULEVARD, SUITE 800
- **CITY:** NORTH BETHESDA
- **STATE:** MD
- **ZIP:** 20852
- **BUSINESS PHONE:** 240-335-7914

**MAIL ADDRESS:**
- **STREET 1:** 6116 EXECUTIVE BOULEVARD, SUITE 800
- **CITY:** NORTH BETHESDA
- **STATE:** MD
- **ZIP:** 20852

?xml version='1.0' encoding='ASCII'? 10-Q

[<u>**Table of Contents**</u>](#toc_page)

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

------

**FORM** 10-Q

------

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**For the quarterly period ended** **September 30,** 2025

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from __________ to __________** 

**Commission File Number:** 001-40546

------

XOMETRY, INC.

**(Exact Name of Registrant as Specified in its Charter)**

------

---

| | |
|:---|:---|
| Delaware | 32-0415449 |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |
| 6116 Executive Blvd <br>Suite 800 <br>North Bethesda**,** MD  | 20852 |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (**240**)** 335-7914

------

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange on which registered** |
| Class A common stock, par value $0.000001 per share | XMTR | The Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| Emerging growth company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 28, 2025, the registrant had 49,772,345 shares of Class A common stock, $0.000001 par value per share, and 1,475,311 shares of Class B common stock, $0.000001 par value per share, outstanding.

------

[<u>**Table of Contents**</u>](#toc_page)

**Table of Contents**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **PART I.** | [<u>FINANCIAL INFORMATION</u>](#financial_information) |  |
| Item 1. | [<u>Financial Statements (Unaudited)</u>](#financial_statements) | 1 |
|  | [<u>Condensed Consolidated Balance Sheets (Unaudited)</u>](#condensed_consolidated_balance_sheets) | 1 |
|  | [<u>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</u>](#condensed_consolidated_statements_of_ope) | 2 |
|  | [<u>Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)</u>](#equity_statement_new) | 3 |
|  | [<u>Condensed Consolidated Statements of Cash Flows</u>](#cash_flows)<u>(Unaudited)</u> | 5 |
|  | [<u>Notes to Condensed Consolidated Financial Statements (Unaudited)</u>](#notes_to_financial_statements) | 6 |
| Item 2. | [<u>Management's Discussion and Analysis of Financial Condition and Results of Operations</u>](#item_2) | 23 |
| Item 3. | [<u>Quantitative and Qualitative Disclosures About Market Risk</u>](#i_item3) | 41 |
| Item 4. | [<u>Controls and Procedures</u>](#i_item4) | 42 |
| **PART II.** | [<u>OTHER INFORMATION</u>](#part_ii) |  |
| Item 1. | [<u>Legal Proceedings</u>](#ii_item1) | 43 |
| Item 1A. | [<u>Risk Factors</u>](#ii_item1a) | 43 |
| Item 2. | [<u>Unregistered Sales of Equity Securities and Use of Proceeds</u>](#ii_item2) | 44 |
| Item 3. | [<u>Defaults Upon Senior Securities</u>](#ii_item3) | 44 |
| Item 4. | [<u>Mine Safety Disclosures</u>](#ii_item4) | 44 |
| Item 5. | [<u>Other Information</u>](#ii_item5) | 44 |
| Item 6. | [<u>Exhibits</u>](#ii_item6) | 45 |
| [<u>Signatures</u>](#signatures) | [<u>Signatures</u>](#signatures) | 46 |

---

i

------

[<u>**Table of Contents**</u>](#toc_page)

**SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "can," "will," "would," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report on Form 10-Q include, but are not limited to, statements about:

• our expectations regarding our revenue, expenses and other operating results;

• the anticipated growth of our business, including our ability to effectively manage or sustain our growth and to achieve or sustain profitability;

• the effects of inflation, interest rates, recessionary factors, foreign exchange rate volatility, tariffs and other trade barriers, the ongoing U.S. government shutdown, domestic and global geopolitical uncertainties, public health crises, supply-chain disruptions or other macroeconomic factors, which may lead to periods of global economic uncertainty;

• future investments in our business, our anticipated capital expenditures and our estimates regarding our capital requirements;

• our ability to attract new buyers and suppliers and successfully engage new and existing buyers and suppliers;

• the costs and success of our sales and marketing efforts, and our ability to promote our brand;

• our reliance on key personnel and our ability to identify, recruit and retain skilled personnel;

• our ability to effectively manage our growth, including any international expansion;

• our ability to obtain, maintain, protect and enforce our intellectual property or other proprietary rights and any costs associated therewith;

• our ability to effectively manage our costs and expenses, which may be impacted by changes in tariff policy and inflationary pressures;

• our ability to compete effectively with existing competitors and new market entrants; and

• the growth rates of the markets in which we compete.

You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled Risk Factors Part II, Item 1A, and elsewhere in this Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Form 10-Q. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Form 10-Q. And while we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.

The forward-looking statements made in this Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Form 10-Q to reflect events or circumstances after the date of this Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

ii

------

[<u>**Table of Contents**</u>](#toc_page)

**PART I—FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

**XOMETRY, INC. AND SUBSIDIARIES** 

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands, except share and per share data)

---

| | | |
|:---|:---|:---|
|  | **September 30,** | **December 31,** |
|  | **2025** | **2024** |
| **Assets** |  |  |
| **Current assets:** |  |  |
| Cash and cash equivalents | $20845 | $22232 |
| Marketable securities | 203674 | 217603 |
| Accounts receivable, less allowance for credit losses of $6.5 million as of September 30, 2025 and $4.9 million as of December 31, 2024 | 98887 | 73962 |
| Inventory | 4241 | 3915 |
| Prepaid expenses | 5904 | 4954 |
| Other current assets | 7554 | 4874 |
| **Total current assets** | 341105 | 327540 |
| Property and equipment, net | 54545 | 44825 |
| Operating lease right-of-use assets | 5333 | 8462 |
| Investment in unconsolidated joint venture | 4209 | 4065 |
| Intangible assets, net | 29456 | 32139 |
| Goodwill | 263770 | 262686 |
| Other assets | 459 | 412 |
| **Total assets** | $698877 | $680129 |
| **Liabilities and stockholders' equity** |  |  |
| **Current liabilities:** |  |  |
| Accounts payable and accrued cost of revenue | $46242 | $35023 |
| Other accrued expenses | 33306 | 24401 |
| Contract liabilities | 11322 | 7948 |
| Income taxes payable | 730 | 979 |
| Operating lease liabilities, current portion | 2547 | 6436 |
| **Total current liabilities** | 94147 | 74787 |
| Convertible notes | 326943 | 283628 |
| Operating lease liabilities, net of current portion | 3965 | 5072 |
| Deferred income taxes | 185 | 229 |
| Other liabilities | 547 | 817 |
| **Total liabilities** | 425787 | 364533 |
| Commitments and contingencies **(Note 9)** |  |  |
| **Stockholders' equity** |  |  |
| Preferred stock, $0.000001 par value. Authorized; 50,000,000 shares; zero shares issued and outstanding as of September 30, 2025 and December 31, 2024 |  |  |
| Class A Common stock, $0.000001 par value. Authorized; 750,000,000 shares; 49,557,368 shares and 48,289,274 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively |  |  |
| Class B Common stock, $0.000001 par value. Authorized; 5,000,000 shares; 1,475,311 shares issued and outstanding as of September 30, 2025 and December 31, 2024 |  |  |
| Additional paid-in capital | 698972 | 685054 |
| Treasury stock, at cost, 220,994 and zero shares as of September 30, 2025 and December 31, 2024, respectively | (8080) |  |
| Accumulated other comprehensive income (loss) | 4454 | (328) |
| Accumulated deficit | (423382) | (370273) |
| **Total stockholders' equity** | 271964 | 314453 |
| **Noncontrolling interest** | 1126 | 1143 |
| **Total equity** | 273090 | 315596 |
| **Total liabilities and stockholders' equity** | $698877 | $680129 |

---

**See accompanying notes to the unaudited condensed consolidated financial statements.** 

------

[<u>**Table of Contents**</u>](#toc_page)

**XOMETRY, INC. AND SUBSIDIARIES** 

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

(In thousands, except share and per share data)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Revenue | $180715 | $141698 | $494234 | $396983 |
| Cost of revenue | 108686 | 85873 | 300698 | 240379 |
| **Gross profit** | 72029 | 55825 | 193536 | 156604 |
| **Operating expenses** |  |  |  |  |
| Sales and marketing | 32649 | 27204 | 88866 | 81891 |
| Operations and support | 18403 | 14698 | 53225 | 42918 |
| Product development | 12524 | 9344 | 34703 | 28952 |
| General and administrative | 19463 | 16060 | 53433 | 47470 |
| Impairment of assets | 49 |  | 49 |  |
| Total operating expenses | 83088 | 67306 | 230276 | 201231 |
| **Loss from operations** | (11059) | (11481) | (36740) | (44627) |
| **Other (expenses) income** |  |  |  |  |
| Interest expense | (1278) | (1187) | (3648) | (3564) |
| Interest and dividend income | 2139 | 2781 | 6591 | 8275 |
| Other expenses | (1636) | (444) | (19882) | (1064) |
| Income from unconsolidated joint venture | 220 | 162 | 544 | 493 |
| Total other (expenses) income | (555) | 1312 | (16395) | 4140 |
| **Loss before income taxes** | (11614) | (10169) | (53135) | (40487) |
| Benefit (provision) for income taxes | 17 | (30) | 25 | (20) |
| **Net loss** | (11597) | (10199) | (53110) | (40507) |
| Net (loss) income attributable to noncontrolling interest |  |  | (1) | 5 |
| **Net loss attributable to common stockholders** | $(11597) | $(10199) | $(53109) | $(40512) |
| Net loss per share, basic and diluted, of Class A and Class B common stock | $(0.23) | $(0.21) | $(1.05) | $(0.83) |
| Weighted-average number of shares outstanding used to compute net loss per share, basic and diluted, of Class A and Class B common stock | 50920588 | 49282164 | 50653997 | 48901475 |
| **Net loss** | $(11597) | $(10199) | $(53110) | $(40507) |
| Comprehensive income (loss): |  |  |  |  |
| Foreign currency translation | 180 | 795 | 4766 | 430 |
| Total other comprehensive income | 180 | 795 | 4766 | 430 |
| **Comprehensive loss** | (11417) | (9404) | (48344) | (40077) |
| Comprehensive income (loss) attributable to noncontrolling interest | 7 | (23) | (17) | 8 |
| **Total comprehensive loss attributable to common stockholders** | $(11424) | $(9381) | $(48327) | $(40085) |

---

**See accompanying notes to the unaudited condensed consolidated financial statements.** 

------

[<u>**Table of Contents**</u>](#toc_page)

**XOMETRY, INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Changes in Stockholders' Equity

(Unaudited)

Three months ended September 30, 2025 and 2024

(In thousands, except share and per share data)

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A - Common Stock** | **Class A - Common Stock** | **Class B - Common Stock** | **Class B - Common Stock** | **Additional Paid-In** | **Treasury Stock** | **Treasury Stock** | **Accumulated Other Comprehensive** | **Accumulated** | **Total Stockholders'** | **Noncontrolling** | **Total** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Capital** | **Shares** | **Amount** | **Income** | **Deficit** | **Equity** | **Interest** | **Equity** |
| Balance, June 30, 2025 | 49107080 | $— | 1475311 | $— | $685986 | 220994 | $(8080) | $4281 | $(411785) | $270402 | $1119 | $271521 |
| Exercise of common stock options | 166305 |  |  |  | 1288 |  |  |  |  | 1288 |  | 1288 |
| Vesting of restricted stock units | 263850 |  |  |  |  |  |  |  |  |  |  |  |
| Donated common stock | 20133 |  |  |  | 950 |  |  |  |  | 950 |  | 950 |
| Stock-based compensation |  |  |  |  | 10748 |  |  |  |  | 10748 |  | 10748 |
| Comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation |  |  |  |  |  |  |  | 173 |  | 173 | 7 | 180 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  |  |  | (11597) | (11597) |  | (11597) |
| Total comprehensive loss |  |  |  |  |  |  |  |  | (11597) | (11424) | 7 | (11417) |
| Balance, September 30, 2025 | 49557368 | $— | 1475311 | $— | $698972 | 220994 | $(8080) | $4454 | $(423382) | $271964 | $1126 | $273090 |
| Balance, June 30, 2024 | 46322810 | $— | 2676154 | $— | $665555 |  | $— | $464 | $(350185) | $315834 | $1150 | $316984 |
| Exercise of common stock options | 277829 |  |  |  | 1420 |  |  |  |  | 1420 |  | 1420 |
| Vesting of restricted stock units | 148029 |  |  |  |  |  |  |  |  |  |  |  |
| Donated common stock | 20133 |  |  |  | 406 |  |  |  |  | 406 |  | 406 |
| Stock-based compensation |  |  |  |  | 6954 |  |  |  |  | 6954 |  | 6954 |
| Comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation |  |  |  |  |  |  |  | 818 |  | 818 | (23) | 795 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  |  |  | (10199) | (10199) |  | (10199) |
| Total comprehensive loss |  |  |  |  |  |  |  |  | (10199) | (9381) | (23) | (9404) |
| Balance, September 30, 2024 | 46768801 | $— | 2676154 | $— | $674335 |  | $— | $1282 | $(360384) | $315233 | $1127 | $316360 |

---

**See accompanying notes to the unaudited condensed consolidated financial statements.**

------

[<u>**Table of Contents**</u>](#toc_page)

**XOMETRY, INC. AND SUBSIDIARIES**

Condensed Consolidated Statements of Changes in Stockholders' Equity

(Unaudited)

Nine months ended September 30, 2025 and 2024

(In thousands, except share and per share data)

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Class A - Common Stock** | **Class A - Common Stock** | **Class B - Common Stock** | **Class B - Common Stock** | **Additional Paid-In** | **Treasury Stock** | **Treasury Stock** | **Accumulated Other Comprehensive** | **Accumulated** | **Total Stockholders'** | **Noncontrolling** | **Total** |
|  | **Shares** | **Amount** | **Shares** | **Amount** | **Capital** | **Shares** | **Amount** | **(Loss) Income** | **Deficit** | **Equity** | **Interest** | **Equity** |
| Balance, December 31, 2024 | 48289274 | $— | 1475311 | $— | $685054 |  | $— | $(328) | $(370273) | $314453 | $1143 | $315596 |
| Exercise of common stock options | 311699 |  |  |  | 2703 |  |  |  |  | 2703 |  | 2703 |
| Vesting of restricted stock units | 1100274 |  |  |  |  |  |  |  |  |  |  |  |
| Shares issued in business combination | 16716 |  |  |  | 625 |  |  |  |  | 625 |  | 625 |
| Donated common stock | 60399 |  |  |  | 2080 |  |  |  |  | 2080 |  | 2080 |
| Purchase of capped calls |  |  |  |  | (17475) |  |  |  |  | (17475) |  | (17475) |
| Purchase of treasury stock | (220994) |  |  |  |  | 220994 | (8080) |  |  | (8080) |  | (8080) |
| Stock-based compensation |  |  |  |  | 25985 |  |  |  |  | 25985 |  | 25985 |
| Comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation |  |  |  |  |  |  |  | 4782 |  | 4782 | (16) | 4766 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  |  |  | (53109) | (53109) | (1) | (53110) |
| Total comprehensive loss |  |  |  |  |  |  |  |  | (53109) | (48327) | (17) | (48344) |
| Balance, September 30, 2025 | 49557368 | $— | 1475311 | $— | $698972 | 220994 | $(8080) | $4454 | $(423382) | $271964 | $1126 | $273090 |
| Balance, December 31, 2023 | 45489379 | $— | 2676154 | $— | $648317 |  | $— | $855 | $(319872) | $329300 | $1119 | $330419 |
| Exercise of common stock options | 502981 |  |  |  | 3215 |  |  |  |  | 3215 |  | 3215 |
| Vesting of restricted stock units | 642833 |  |  |  |  |  |  |  |  |  |  |  |
| Exercise of warrants | 52126 |  |  |  |  |  |  |  |  |  |  |  |
| Shares issued in business combination | 21083 |  |  |  | 625 |  |  |  |  | 625 |  | 625 |
| Donated common stock | 60399 |  |  |  | 1063 |  |  |  |  | 1063 |  | 1063 |
| Stock-based compensation |  |  |  |  | 21115 |  |  |  |  | 21115 |  | 21115 |
| Comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation |  |  |  |  |  |  |  | 427 |  | 427 | 3 | 430 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss) income |  |  |  |  |  |  |  |  | (40512) | (40512) | 5 | (40507) |
| Total comprehensive (loss) income |  |  |  |  |  |  |  |  | (40512) | (40085) | 8 | (40077) |
| Balance, September 30, 2024 | 46768801 | $— | 2676154 | $— | $674335 |  | $— | $1282 | $(360384) | $315233 | $1127 | $316360 |

---

**See accompanying notes to the unaudited condensed consolidated financial statements.**

------

[<u>**Table of Contents**</u>](#toc_page)

**XOMETRY, INC. AND SUBSIDIARIES** 

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| Net loss | $(53110) | $(40507) |
| Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| Depreciation and amortization | 13741 | 9622 |
| Impairment of assets | 49 |  |
| Reduction in carrying amount of right-of-use asset | 3350 | 3328 |
| Lease termination | (14) |  |
| Stock-based compensation | 25985 | 21115 |
| Revaluation of contingent consideration |  | 137 |
| Income from unconsolidated joint venture | (144) | (93) |
| Donation of common stock | 2080 | 1063 |
| Loss on debt extinguishment | 16430 |  |
| Gain on sale of property and equipment |  | (23) |
| Amortization of deferred costs on convertible notes | 1527 | 1394 |
| Deferred tax benefit | (44) | (30) |
| Changes in other assets and liabilities: |  |  |
| Accounts receivable, net | (23370) | (8263) |
| Inventory | (192) | (598) |
| Prepaid expenses | (904) | 786 |
| Other assets | (1233) | 4354 |
| Accounts payable and accrued cost of revenue | 10728 | (18293) |
| Other accrued expenses | 9100 | 6782 |
| Contract liabilities | 3170 | 916 |
| Lease liabilities | (5202) | (5068) |
| Other liabilities | (24) | 529 |
| Income taxes payable | (249) | (1620) |
| **Net cash provided by (used in) operating activities** | 1674 | (24469) |
| **Cash flows from investing activities:** |  |  |
| Purchases of marketable securities | (6571) | (16253) |
| Proceeds from sale of marketable securities | 20500 | 15000 |
| Purchases of property and equipment | (19911) | (13560) |
| Proceeds from sale of property and equipment |  | 79 |
| **Net cash used in investing activities** | (5982) | (14734) |
| **Cash flows from financing activities:** |  |  |
| Proceeds from issuance of convertible notes | 250000 |  |
| Costs incurred in connection with issuance of convertible notes | (8650) |  |
| Payments for repurchase of convertible notes | (215992) |  |
| Purchase of capped calls | (17475) |  |
| Purchase of treasury stock | (8080) |  |
| Proceeds from stock options exercised | 2703 | 3215 |
| **Net cash provided by financing activities** | 2506 | 3215 |
| Effect of foreign currency translation on cash and cash equivalents | 415 | (6) |
| **Net decrease in cash and cash equivalents** | (1387) | (35994) |
| **Cash and cash equivalents at beginning of the period** | 22232 | 53424 |
| **Cash and cash equivalents at end of the period** | $20845 | $17430 |
| **Supplemental cash flow information:** |  |  |
| Cash paid for interest | $2600 | $2875 |
| **Non-cash investing and financing activities:** |  |  |
| Non-cash purchase of property and equipment | 74 |  |
| Non-cash consideration in connection with business combination | 625 |  |

---

**See accompanying notes to the unaudited condensed consolidated financial statements.**

------

[<u>**Table of Contents**</u>](#toc_page)

**XOMETRY, INC. AND SUBSIDIARIES** 

Notes to Unaudited Condensed Consolidated Financial Statements

(Unaudited)

**(1) Organization and Description of Business** 

Xometry, Inc. ("Xometry", the "Company", "we", or "our") was incorporated in the State of Delaware in May 2013 and our corporate headquarters is located in North Bethesda, Maryland. Xometry operates a global artificial intelligence ("AI") powered online manufacturing marketplace, a leading North American industrial sourcing platform Thomasnet® and a suite of cloud-based services including Workcenter and Teamspace that are rapidly digitizing the manufacturing industry. Together, these platforms provide manufacturers the critical resources they need to grow their business and make it easy for buyers to create resilient supply chains. Xometry's marketplaces use proprietary AI to help buyers efficiently source custom-manufactured parts and assemblies and attain instant pricing and lead times. The AI enables our rapidly growing network of manufacturers to select the optimal jobs to fill their capacity. Our suite of cloud-based services and our Thomasnet industrial sourcing platform helps manufacturers and industrial service providers grow their businesses using our advertising, marketing and financial services.

We use proprietary technology to enable product designers, engineers, buyers and supply chain professionals to instantly access the capacity of a global network of manufacturing facilities. The Company's platform makes it possible for buyers to quickly receive pricing, expected lead times, manufacturability feedback and place orders on the Company's platform. The network allows the Company to provide high volumes of unique parts, including custom components and assemblies for its buyers, as well as larger production orders of single parts. Xometry's Teamspace offers enterprise-wide collaboration software that unites engineers, managers and purchasing executives to expedite procurement of custom-manufacturing services. We continue to improve features on Xometry and expand the offering with the launch of Teamspace in Europe in the second quarter of 2025.

Xometry marketplace offers buyers an expanding number of manufacturing categories including computer numerical control manufacturing, sheet metal forming, sheet cutting, 3D printing, die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending from rapid prototyping and to high-volume production. As well, we are expanding the number of certifications, materials and finishing options on the platform. Xometry's extensible technology platform allows the Company to expand technologies and processes to gain more wallet share with our buyers.

We empower suppliers to grow their manufacturing businesses and improve machine utilization by providing access to an extensive, diverse base of buyers. We also offer suppliers supporting services to meet their unique needs. The Thomasnet product sourcing and supplier discovery digital platform provides access to in-depth profiles of 500,000 North American suppliers. Thomas' suite of advertising services provides suppliers with tailored marketing campaigns to maximize their visibility and enhance engagement with potential buyers. Thomas' in-house digital marketing agency, Thomas Marketing Services, offers a range of essential digital marketing services to generate leads and boost the awareness and reach of suppliers. In addition, our supplier services include financial service products to facilitate faster payments and a cloud-based manufacturing execution system ("Workcenter") to help suppliers optimize their productivity. Workcenter digitally enables qualifying and on-boarding suppliers and allows suppliers to manage all their Xometry and non-Xometry work and provides for expedited payment terms in support of their business.

**(2) Basis of Presentation and Summary of Significant Accounting Policies** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(a)*** ***Basis of Presentation*** 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP") and applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K filed with the SEC on February 25, 2025.

------

[<u>**Table of Contents**</u>](#toc_page)

The Condensed Consolidated Balance Sheet as of December 31, 2024, included herein, was derived from the audited financial statements as of that date, but may not include all disclosures including certain notes required by U.S. GAAP on an annual reporting basis. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, stockholders' equity and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full year 2025 or any future period. The Company has two reportable segments which are referred to as: (1) the United States ("U.S.") and (2) International.

*Foreign Operations and Comprehensive Loss* 

The U.S. dollar ("USD") is the functional currency for Xometry's consolidated subsidiary operating in the U.S. The primary functional currency for the Company's consolidated subsidiaries operating in Germany and to a lesser extent, United Kingdom, Turkey, China and Japan, is the Euro, British Pound Sterling, Turkish Lira, Yuan and the Yen, respectively. For the Company's consolidated subsidiaries whose functional currencies are not the USD, the Company translates their financial statements into USD. The Company translates assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from translation are included in accumulated other comprehensive (loss) income, as a separate component of equity.

*Noncontrolling Interest*

We have a 66.67% ownership in Incom Co., LTD. As we have a controlling interest in Incom Co., LTD, we have consolidated Incom Co., LTD into our unaudited condensed consolidated financial statements. The portion of equity in Incom Co., LTD not owned by the Company is accounted for as a noncontrolling interest. We present the portion of any equity that we do not own in a consolidated entity as noncontrolling interest and classify their interest as a component of total equity, separate from total stockholders' equity on our Condensed Consolidated Balance Sheets. We include net (loss) income attributable to the noncontrolling interests in net loss in our Condensed Consolidated Statements of Operations and Comprehensive Loss.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(b)*** ***Use of Estimates***

The preparation of the Company's unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(c)*** ***Business Combinations*** 

The Company accounts for business combinations using the acquisition method of accounting, which requires, among other things, allocation of the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to the valuation of intangible assets. Management's estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, the Company may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill if new information is obtained related to facts and circumstances that existed as of the acquisition date. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are reflected in the consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(d)*** ***Fair Value Measurements and Financial Instruments*** 

The Company measures certain assets and liabilities at fair value on a recurring basis based on an expected exit price, which represents the amount that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability.

The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis, whereby inputs used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value:

Level 1 - Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 - Unobservable inputs reflecting the Company's own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

------

[<u>**Table of Contents**</u>](#toc_page)

The carrying amounts of certain of the Company's financial instruments, which include cash and cash equivalents, accounts receivable, prepaid expenses, other assets, accounts payable, accrued expenses and contract liabilities approximate their fair values due to their short maturities. The Company's marketable securities are recorded at fair value.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(e)*** ***Cash and Cash Equivalents***

Cash and cash equivalents consist of cash held in checking accounts. These investments are stated at cost, which approximates fair value.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(f)*** ***Marketable Securities***

The Company measures its marketable securities at fair value. The Company's marketable securities represent our investments in a short-term money market fund. These marketable securities have maturities of three months or less. As of September 30, 2025 and December 31, 2024, the Company's marketable securities of $203.7 million and $217.6 million, respectively, were recorded at fair value, within Level 1 of the fair value hierarchy. The fair value of the Company's Level 1 financial instruments is based on quoted prices in active markets, and total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs, discounts or blockage factors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(g)*** ***Accounts Receivable*** 

Accounts receivable are stated at the amount the Company expects to collect from outstanding balances. The Company's accounts receivable do not bear interest. Amounts collected on accounts receivable are included in net cash used in operating activities in the Condensed Consolidated Statements of Cash Flows. For buyers for which the Company provides credit, the Company performs credit inquiries, including reference checks, and queries credit ratings services and other publicly available information. Management provides for probable uncollectible amounts through a provision for bad debt expense and an adjustment to a valuation allowance based on the age of the outstanding amounts, each customer's expected ability to pay and collection history, current market conditions and reasonable and supportable forecasts of future economic conditions to determine whether the allowance is appropriate. The Company reviews its valuation allowance monthly. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Balances that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to accounts receivable.

*Allowance for Credit Losses*

The allowance for credit losses related to accounts receivable and changes were as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Allowance for credit losses |  |  |
| Balance at beginning of year, January 1 | $4912 | $2444 |
| Charge to provision accounts | 5322 | 4024 |
| Write-offs or other | (3685) | (1556) |
| Balance at period end, September 30 and December 31, respectively | $6549 | $4912 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(h)*** ***Property and Equipment and Long-Lived Assets*** 

Property and equipment are stated at cost. Depreciation is calculated on the straight-line method over the estimated useful life of the assets, which range from two to ten years, or in the case of leasehold improvements, over the shorter of the remaining lease term or the useful life of the asset.

Property and equipment and intangible assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group to be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market values and third-party independent appraisals, as considered necessary.

Property and equipment includes capitalized internal-use software development costs. Eligible internal-use software development costs are capitalized subsequent to the completion of the preliminary project stage. Such costs include internal and external direct development costs totaling $18.9 million for the nine months ended September 30, 2025 and $17.0 million for the year ended December 31, 2024. After all substantial testing and deployment is completed and the software is ready for its intended use, capitalization is discontinued and the internal-use software costs are placed in service and amortized using the straight-line method over the estimated useful life of the software, generally three years.

------

[<u>**Table of Contents**</u>](#toc_page)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(i)*** ***Goodwill*** 

Goodwill represents the excess purchase price over the estimated fair value of net assets acquired in a business combination. As of September 30, 2025 and December 31, 2024, the Company's goodwill is attributable to both the U.S. and International reporting units. Goodwill is not amortized. The Company tests goodwill for impairment annually in the fourth quarter, or more frequently, if events or changes in circumstances indicate that the carrying value of a reporting unit, including goodwill, might be impaired.

In testing for goodwill impairment, we first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. These qualitative factors assessed may include the following: (i) significant changes in the manner of our use of the assets or the strategy of our overall business, (ii) certain restructuring initiatives, (iii) significant negative industry or economic trends and (iv) significant decline in our share price for a sustained period. If, after assessing the totality of events or circumstances, we determine it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then additional impairment testing is not required. However, if we conclude otherwise, we proceed to the quantitative assessment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(j)*** ***Revenue***

The Company derives the majority of its U.S. and International marketplace revenue from the sale of parts and assemblies fulfilled using a vast network of suppliers. The Company recognizes revenue from the sales to our customers pursuant to the Financial Accounting Standard Board's ("FASB") Accounting Standards Codification *Topic 606, Revenue from Contracts with Customers*.

The Company determines that a contract exists between the Company and the customer when the customer accepts the quote and places the order, all of which are governed by the Company's standard terms and conditions or other agreed terms with Xometry's customers. Upon completion of an order through Xometry's platform, the Company identifies the performance obligation(s) within that order to complete the sale of the manufactured part(s) or assembly. Using Xometry's in-house technology, the Company determines the price for the manufactured part(s) or assembly on a stand-alone basis at order initiation. The Company recognizes revenue from sales to Xometry's customers upon shipment, at which point control over the part(s) or assembly has transferred.

The Company has concluded that the Company is principal in the sale of part(s) and assemblies that use the Company's network of third-party manufacturers because the Company controls the manufacturing by obtaining a right to direct a third-party manufacturer to fulfill the performance obligation Xometry has with the Company's customers on Xometry's behalf. The Company has considered the following conditions of the sale: (i) the Company has the obligation of providing the specified product to the customer, (ii) the Company has discretion with respect to establishing the price of the product and the price the Company pays the suppliers and the Company has margin risk on all of Xometry's sales, (iii) the Company has discretion in determining how to fulfill each order, including selecting the supplier and (iv) Xometry bears certain risk for product quality to the extent the customer is not satisfied with the final product.

Xometry also derives revenue from its supplier services which is a suite of services offered to our suppliers. Revenue also includes the sale of marketing services which includes advertising. This revenue is generally recognized as control is transferred to the customer, in an amount reflecting the consideration we expect to be entitled to in exchange for such product or service. From time to time, a purchase order with a customer may involve multiple performance obligations, including a combination of some or all of our products. Judgment may be required in determining whether products are considered distinct performance obligations that should be accounted for separately or as one combined performance obligation. Revenue is recognized over the period or at the point in time in which the performance obligations are satisfied. Consideration is typically determined based on a fixed unit price for the quantity of product transferred. For purchase orders involving multiple performance obligations, the transaction price is allocated to each performance obligation based on relative standalone selling price, and recognized as revenue when each individual product or service is transferred to the customer.

Revenue is shown net of estimated returns, refunds, and allowances. At September 30, 2025 and December 31, 2024, the Company has a provision for estimated returns, refunds or allowances of approximately $0.2 million and $0.1 million, respectively.

Sales tax and, if applicable, duties and/or tariffs collected from customers and remitted to governmental authorities is excluded from revenue.

*Contract Liabilities* 

Contract liabilities are primarily derived from payments received in advance or at the time an order is placed, for which the associated performance obligations have not been satisfied and revenue has not been recognized based on the Company's revenue recognition criteria described above.

The following table presents contract liabilities as of December 31, 2024 and September 30, 2025 (in thousands):

---

| | |
|:---|:---|
| Rollforward of contract liabilities: |  |
| Contract liabilities at December 31, 2024 | $7948 |
| Revenue recognized | (169669) |
| Payments received in advance | 173043 |
| Contract liabilities at September 30, 2025 | $11322 |

---

------

[<u>**Table of Contents**</u>](#toc_page)

During the nine months ended September 30, 2025, the Company recognized approximately $7.3 million of revenue related to its contract liabilities as of December 31, 2024.

*Sales Contract Acquisition Costs* 

The Company's incremental costs to obtain a contract may include a sales commission which is generally determined on a per-order basis. For marketplace contracts, sales commissions are generally expensed as incurred. For supplier service contracts in excess of one year, the Company amortizes such costs on a straight-line basis over the average customer life of two years for new customers and over the renewal period for existing customers which is generally one year. Sales commissions are included in the Company's sales and marketing expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss. For the three and nine months ended September 30, 2025, the Company recognized approximately $0.7 million and $2.1 million, respectively, of amortization related to deferred sales commissions. For the three and nine months ended September 30, 2024, the Company recognized approximately $1.3 million and $5.7 million, respectively, of amortization related to deferred sales commissions. As of September 30, 2025 and December 31, 2024, the Company had deferred sales contract acquisition costs of $0.4 million for both periods, which is classified in other current assets on the Condensed Consolidated Balance Sheets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(k)*** ***Cost of Revenue***

Cost of revenue for marketplace primarily consists of the cost of the products that are manufactured or produced by the Company's suppliers for delivery to buyers on the Company's platform, internal and external production costs, shipping costs, and certain internal depreciation.

Cost of revenue for supplier services primarily consists of internal and external production costs and website hosting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(l)*** ***Leases*** 

The Company determines if an arrangement contains a lease and the classification of that lease, if applicable, at its inception. Operating leases are included in operating lease right-of-use ("ROU") assets, operating lease liabilities, current portion and operating lease liabilities, net of current portion in the Condensed Consolidated Balance Sheets. For leases with terms of twelve months or less, the Company does not recognize ROU assets or lease liabilities on the Condensed Consolidated Balance Sheets. Additionally, the Company elected to use the practical expedient to not separate lease and non-lease components for leases of real estate, meaning that for these leases, the non-lease components are included in the associated ROU asset and lease liability balances on the Company's Condensed Consolidated Balance Sheets.

ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments under the lease. Operating lease ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The implicit rate within the Company's operating leases is generally not determinable, as such the Company uses its incremental borrowing rate at lease commencement to determine the present value of lease payments. The operating lease ROU asset also includes any lease prepayments, offset by lease incentives. Certain of the Company's leases include options to extend or terminate the lease. The expected lease term includes options to extend or terminate the lease when it is reasonably certain the Company will exercise such option.

Lease expense is recognized on a straight-line basis over the term of the lease.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(m)*** ***Sales and Marketing***

Sales and marketing expenses are expensed as incurred and include the costs of digital marketing strategies, branding costs and other advertising costs, certain depreciation and amortization expense, contract acquisition costs and compensation expenses, including stock-based compensation, to the Company's sales and marketing employees. For the three and nine months ended September 30, 2025, the Company's advertising costs were $9.2 million and $25.3 million, respectively. For the three and nine months ended September 30, 2024, the Company's advertising cost were $9.4 million and $26.5 million, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(n)*** ***Operations and Support***

Operations and support expenses are the costs the Company incurs in support of the customers and suppliers on Xometry's platforms which are provided by phone, email and chat for purposes of resolving customer and supplier related matters. These costs primarily consist of compensation expenses of the support staff, including stock-based compensation, certain depreciation and amortization expense and software costs used in delivering customer and supplier services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(o)*** ***Product Development*** 

Product development costs which are not eligible for capitalization are expensed as incurred. These costs primarily consist of compensation expenses, including stock-based compensation to the Company's employees performing routine improvements and maintenance on our platforms not related to a specific capitalizable project, software costs and certain depreciation and amortization expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(p)*** ***General and Administrative*** 

General and administrative expenses primarily consist of compensation expenses, including stock-based compensation expenses, for executive, finance, legal and other administrative personnel, professional service fees and certain depreciation and amortization expense.

------

[<u>**Table of Contents**</u>](#toc_page)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(q)*** ***Stock-Based Compensation*** 

All stock-based compensation, including stock options, restricted stock units and performance restricted stock units ("PRSUs"), are measured at the grant date fair value of the award. The fair value of the restricted stock units and PRSUs is determined using the fair value of the Company's Class A common stock on the date of grant. The Company estimates grant date fair value of stock options using the Black-Scholes option-pricing model. The fair value of stock options, PRSUs and restricted stock units is recognized as compensation expense on a straight-line basis over the requisite service period, which is typically three to four years. Forfeitures are recorded in the period in which they occur.

The Black-Scholes model considers several variables and assumptions in estimating the fair value of stock-based awards.

These variables include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expected annual dividend yield;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expected volatility over the expected term;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expected term;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risk free interest rate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• per share value of the underlying common stock; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• exercise price.

For all stock options granted, the Company calculated the expected term using the simplified method for "plain vanilla" stock option awards. The risk-free interest rate is based on the yield available on U.S. Treasury issuances similar in duration to the expected term of the stock-based award. The Company estimates its expected share price volatility based on the historical volatility of publicly traded peer companies and/or its own volatility and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded share price. The Company utilized a dividend yield of zero, as it had no history or plan of declaring dividends on its common stock.

The fair value for PRSUs is recognized on a ratable basis over the requisite service period of three years when it is probable the performance conditions of the awards will be met. The Company reassesses the probability of vesting at each reporting period and adjusts the total compensation expense of the award based on this probability assessment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(r)*** ***Net Loss Per Share Attributable to Common Stockholders***

The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Certain unvested share-based payment awards that contain nonforfeitable rights to dividends are treated as participating securities and therefore included in computing net income per share using the two-class method. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share proportionately in the Company's net losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(s)*** ***Recently Adopted Accounting Standards***

In November 2023, the FASB issued Accounting Standard Update ("ASU") No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires a public entity to disclose significant segment expenses and other segment items on an annual and interim basis and provide in interim periods all disclosures about a reportable segment's profit or loss and assets that are currently required annually. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker ("CODM"). The ASU did not change how a public entity identifies its operating segments, aggregates them, or applies the quantitative thresholds to determine its reportable segments. The new standard became effective for the Company in December 2024. The Company applied the amendments in this ASU retrospectively to all prior periods presented in the financial statements. We have reflected the adoption of this ASU in Note 5, *Segments.*

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which focuses on the rate reconciliation and income taxes paid. ASU No. 2023-09 requires a public business entity ("PBE") to disclose, on an annual basis, a tabular rate reconciliation using both percentages and currency amounts, broken out into specified categories with certain reconciling items further broken out by nature and jurisdiction to the extent those items exceed a specified threshold. In addition, all entities are required to disclose income taxes paid, net of refunds received, disaggregated by federal, state/local and foreign and by jurisdiction if the amount is at least 5% of total income tax payments, net of refunds received. The Company adopted this new standard in 2025 and applied the amendments prospectively. The adoption of this new standard does not impact our results of operations, cash flows, and financial condition.

------

[<u>**Table of Contents**</u>](#toc_page)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***(t)*** ***Recently Issued Accounting Standards***

In November 2024, the FASB issued ASU No. 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"). Under ASU 2024-03, a PBE would be required to disclose information about purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. ASU 2024-03 allows for early adoption and requires either prospective adoption to financial statements issued for reporting periods after the effective date of ASU 2024-03 or retrospective adoption to any or all prior periods presented in the financial statements. The Company is currently assessing the impact of ASU 2024-03 on our consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU No. 2024-04, Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments ("ASU 2024-04"), which clarifies the assessment of whether certain settlements of convertible debt instruments should be accounted for as an inducement conversion or extinguishment of convertible debt. The new guidance is effective for annual reporting periods beginning after December 15, 2025, and interim periods within those annual periods. The Company is currently assessing the impact of ASU 2024-04 on our consolidated financial statements and related disclosures.

In May 2025, the FASB issued ASU No. 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity ("ASU 2025-03"), which requires that in a business combination involving a variable interest entity ("VIE") where equity interests are issued as consideration, the determination of the accounting acquirer should follow the general guidance under ASC 805-10-25 rather than default to the conclusion that the acquirer is primary beneficiary of the VIE. The amendments are intended to improve consistency in applying the acquisition method to business combinations. The new guidance is effective for annual reporting periods beginning after December 15, 2026, and interim periods within those annual periods. The Company is currently assessing the impact of ASU 2025-03 on our consolidated financial statements and related disclosures, including the potential impact on the accounting for any future business combinations involving VIEs.

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets, which amends ASC 326-20 to provide a practical expedient (for all entities) and an accounting policy election (for all entities, other than public business entities that elect the practical expedient) related to the estimation of expected credit losses for current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606. The new guidance is effective for annual reporting periods beginning after December 15, 2025, and interim periods within those annual periods. The Company is currently assessing the impact of ASU 2025-05 on our consolidated financial statements and related disclosures.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which improves the operability of the guidance by removing all references to software development project stages so that the guidance is neutral to different software development methods. The new guidance is effective for annual periods beginning after December 15, 2027, and interim periods within those annual periods. The Company is currently assessing the impact of ASU 2025-06 on our consolidated financial statements and related disclosures.

There are currently no other accounting standards that have been issued, but not yet adopted, that are expected to have a significant impact on the Company's consolidated financial position, results of operations or statement of cash flows upon adoption.

**(3) Property and Equipment and Long-Lived Assets** 

Property and equipment consist of the following as of September 30, 2025 and December 31, 2024 (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  |  | **September 30,** | **December 31,** |
|  | **Useful Life** | **2025** | **2024** |
| Technology hardware | 3 years | $4379 | $3884 |
| Manufacturing equipment | 2 - 10 years | 6690 | 6572 |
| Capitalized software development | 3 years | 80450 | 60480 |
| Leasehold improvements | Shorter of useful life or lease term | 1731 | 1761 |
| Furniture and fixtures | 7 years | 3067 | 2549 |
| Total |  | 96317 | 75246 |
| Less accumulated depreciation |  | (41772) | (30421) |
| Property and Equipment, net |  | $54545 | $44825 |

---

------

[<u>**Table of Contents**</u>](#toc_page)

Depreciation and amortization expense for the three and nine months ended September 30, 2025 and 2024 was as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Cost of revenue | $184 | $183 | $550 | $549 |
| Sales and marketing | 29 | 24 | 75 | 77 |
| Operations and support | 46 | 32 | 129 | 105 |
| Product development | 3693 | 1940 | 9770 | 5786 |
| General and administrative | 155 | 127 | 539 | 384 |
| Total depreciation and amortization expense | $4107 | $2306 | $11063 | $6901 |

---

**(4) Disaggregated Revenue and Cost of Revenue Information**

The following tables present our revenues disaggregated by line of business. Revenue from our marketplace primarily reflects the sales of parts and assemblies on our platform. Revenue from supplier services primarily includes the sale of digital advertising and marketing services, and to a lesser extent financial service products and SaaS products.

Revenue and cost of revenue is presented in the following tables for the three and nine months ended September 30, 2025 and 2024, respectively (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| **Marketplace** | **2025** | **2024** | **2025** | **2024** |
| Revenue | $166592 | $126965 | $451168 | $351438 |
| Cost of revenue | 107086 | 84347 | 295891 | 235278 |
| Gross Profit | $59506 | $42618 | $155277 | $116160 |
| **Supplier Services** |  |  |  |  |
| Revenue | $14123 | $14733 | $43066 | $45545 |
| Cost of revenue | 1600 | 1526 | 4807 | 5101 |
| Gross Profit | $12523 | $13207 | $38259 | $40444 |

---

**(5) Segments** 

Xometry is organized in two segments referred to as: (1) U.S. and (2) International. Xometry's operating segments are also the Company's reportable segments. Xometry's reportable segments are managed separately based on geography. The Company's U.S. revenues primarily result from the sale of parts and assemblies and the sale of advertising and marketing services. The Company's International revenues primarily result from the sale of parts and assemblies. Xometry's two segments are defined based on the reporting and review process used by the CODM, the Chief Executive Officer.

The Company evaluates the performance of the operating segments primarily based on revenue and segment Adjusted EBITDA. The CODM uses actual results compared to budgeted or forecasted segment Adjusted EBITDA to determine if the reporting units are making progress toward profitability and when making decisions about the allocation of resources and the assessment of performance. In 2024, the Company determined that revenue and segment profit before income taxes were its measures of segment performance. In December 2024, the Company changed its segment profit or loss measure to segment Adjusted EBITDA based on a reassessment of the information currently used by the CODM to allocate resources and assess performance of the segments. The Company has recast segment Adjusted EBITDA for the prior periods.

Segment Adjusted EBITDA excludes interest expense, interest and dividend income, other expenses, benefit for income taxes, and certain other non-cash or non-recurring items impacting net loss from time to time, principally comprised of depreciation and amortization, amortization of lease intangible, stock-based compensation, payroll tax expense related to stock-based compensation, charitable contributions of common stock, income from an unconsolidated joint venture, restructuring charges and acquisition and other adjustments not reflective of our ongoing business, such as adjustments related to purchase accounting, the revaluation of contingent consideration, transaction costs and executive severance.

The CODM monitors assets of the consolidated Company, but does not use assets, by operating segment when assessing performance or making operating segment resource decisions.

------

[<u>**Table of Contents**</u>](#toc_page)

The following tables reflect certain segment information for the three and nine months ended September 30, 2025 and 2024 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Segment Revenue |  |  |  |  |
| U.S. | $151093 | $117584 | $414646 | $333113 |
| International | 29622 | 24114 | 79588 | 63870 |
| Total | $180715 | $141698 | $494234 | $396983 |
| Segment Cost of Revenue |  |  |  |  |
| U.S. | $90933 | $70862 | $251841 | $200829 |
| International | 17753 | 15011 | 48857 | 39550 |
| Total | $108686 | $85873 | $300698 | $240379 |
| Segment Adjusted Operating Expense<sup>(1)</sup> |  |  |  |  |
| U.S. | $49995 | $45516 | $143121 | $136681 |
| International | 16076 | 11124 | 40819 | 31197 |
| Total | $66071 | $56640 | $183940 | $167878 |
| Other Segment Items<sup>(2)</sup> |  |  |  |  |
| U.S. | $(184) | $(183) | $(550) | $(549) |
| International |  |  |  |  |
| Total | $(184) | $(183) | $(550) | $(549) |
| Segment Adjusted EBITDA |  |  |  |  |
| U.S. | $10349 | $1389 | $20234 | $(3848) |
| International | (4207) | (2021) | (10088) | (6877) |
| Total Adjusted EBITDA | $6142 | $(632) | $10146 | $(10725) |
| (Add) deduct: |  |  |  |  |
| Interest expense, interest and dividend income and other expenses | (775) | 1150 | (16939) | 3647 |
| Depreciation and amortization | (5000) | (3213) | (13741) | (9622) |
| Amortization of lease intangible | (180) | (180) | (540) | (540) |
| Benefit (provision) for income taxes | 17 | (30) | 25 | (20) |
| Stock-based compensation | (10748) | (6954) | (25985) | (21115) |
| Payroll tax expense related to stock-based compensation | (366) | (96) | (2100) | (876) |
| Acquisition and other |  |  | (927) | (686) |
| Charitable contribution of common stock | (950) | (406) | (2080) | (1063) |
| Income from unconsolidated joint venture | 220 | 162 | 544 | 493 |
| Impairment of assets | (49) |  | (49) |  |
| Restructuring charges | 92 |  | (1464) |  |
| Net Loss | $(11597) | $(10199) | $(53110) | $(40507) |

---

(1) Amount excludes stock-based compensation and the related payroll taxes, depreciation and amortization, restructuring charges, acquisition and other costs, amortization of lease intangible, lease termination and charitable contributions of common stock.

(2) Addback to Segment Cost of Revenue to calculate Segment Adjusted EBITDA.

------

[<u>**Table of Contents**</u>](#toc_page)

The following tables reflect long-lived asset information as of September 30, 2025 and December 31, 2024 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **September 30,** | **December 31,** |
|  | **2025** | **2024** |
| Segment Property and equipment, net |  |  |
| U.S. | $44347 | $37370 |
| International | 10198 | 7455 |
| Total | $54545 | $44825 |
| Operating lease right-of-use assets |  |  |
| U.S. | $4931 | $7728 |
| International | 402 | 734 |
| Total | $5333 | $8462 |

---

**(6) Stock-Based Compensation** 

In 2014, the Company adopted a stock compensation plan (the "2014 Equity Incentive Plan") pursuant to which the Company may grant stock options, stock purchase rights, restricted stock awards, or stock awards to employees, directors and consultants (including prospective employees, directors, and consultants). This plan was terminated in February 2016. No additional awards may be granted under the 2014 Equity Incentive Plan, however, outstanding awards continue in full effect in accordance with their existing terms.

In 2016, the Company adopted a stock compensation plan (the "2016 Equity Incentive Plan") pursuant to which the Company may grant stock options, stock purchase rights, restricted stock awards, or stock awards to employees, directors and consultants (including prospective employees, directors, and consultants). No additional awards may be granted under the 2016 Equity Incentive Plan, however, outstanding awards continue in full effect in accordance with their existing terms.

In connection with the Company's initial public offering on July 2, 2021, the Company's board of directors adopted the 2021 Equity Incentive Plan (the "2021 Equity Incentive Plan"). The 2021 Equity Incentive Plan provides for the grant of incentive stock options ("ISOs"), non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based awards and other awards, or collectively, awards. Awards may be granted to Xometry employees, Xometry's non-employee directors and consultants/contractors and the employees and consultants/contractors of Xometry affiliates. ISOs may be granted only to Xometry employees and the employees of Xometry affiliates.

As of September 30, 2025, there were 7,368,577 shares available for the Company to grant under the 2021 Equity Incentive Plan.

**Stock Options**

A summary of the status of the Company's stock option activity and the changes during the nine months ended September 30, 2025, are as follows (in millions, except share and per share amounts):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of<br>Shares** | **Weighted<br>Average<br>Exercise Price<br>Per Share** | **Average<br>Remaining<br>Contractual<br>Term** | **Aggregate<br>Intrinsic<br>Value** |
| Exercisable at December 31, 2024 | 1640638 | $10.12 | 5.7 | $53.4 |
| Balance at December 31, 2024 | 1906483 | $11.51 | 6.0 | $59.4 |
| Granted |  |  |  |  |
| Exercised | (310537) | $8.68 |  |  |
| Forfeited | (35679) | $19.17 |  |  |
| Expired | (24490) | $29.25 |  |  |
| Balance at September 30, 2025 | 1535777 | $11.62 | 5.2 | $65.8 |
| Exercisable at September 30, 2025 | 1418270 | $10.97 | 5.1 | $61.7 |

---

No options were granted during the nine months ended September 30, 2025. The total intrinsic value of options exercised during the nine months ended September 30, 2025 and 2024, was $8.9 million and $6.3 million, respectively.

At September 30, 2025, there was approximately $1.2 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted average period of approximately one year as of September 30, 2025.

The Company currently uses authorized and unissued shares to satisfy share award exercises.

------

[<u>**Table of Contents**</u>](#toc_page)

**Restricted Stock Units**

A summary of the status of the Company's restricted stock unit activity and the changes during the nine months ended September 30, 2025 are as follows (in millions, except share and per share amounts):

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of<br>Shares** | **Weighted<br>Average<br>Grant Date fair value (per share)** | **Aggregate<br>Intrinsic<br>Value** |
| Unvested RSUs as of December 31, 2024 | 2530358 | $19.15 | $107.9 |
| Granted | 1967124 | $28.51 |  |
| Vested | (994479) | $20.44 |  |
| Forfeited and cancelled | (443839) | $21.36 |  |
| Unvested RSUs as of September 30, 2025 | 3059164 | $24.43 | $166.6 |

---

At September 30, 2025, there was approximately $63.0 million of total unrecognized compensation cost related to unvested restricted stock units granted under the 2021 Equity Incentive Plan. That cost is expected to be recognized over a weighted average period of approximately three years as of September 30, 2025.

**Performance Restricted Stock Units**

A summary of the status of the Company's performance restricted stock unit activity and the changes during the nine months ended September 30, 2025 are as follows (in millions, except share and per share amounts):

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of<br>Shares** | **Weighted<br>Average<br>Grant Date fair value (per share)** | **Aggregate<br>Intrinsic<br>Value** |
| Unvested PRSUs as of December 31, 2024 | 272515 | $17.32 | $11.6 |
| Granted | 336094 | $23.14 |  |
| Vested | (91527) | $17.32 |  |
| Forfeited and cancelled | (48367) | $20.26 |  |
| Unvested PRSUs as of September 30, 2025 | 468715 | $21.19 | $25.5 |

---

At September 30, 2025, there was approximately $9.6 million of total unrecognized compensation cost related to unvested performance restricted stock units granted under the 2021 Equity Incentive Plan. That cost is expected to be recognized over a weighted average period of approximately two years as of September 30, 2025.

Total stock-based compensation cost for the three and nine months ended September 30, 2025 and 2024 were as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Sales and marketing | $3059 | $1905 | $7282 | $5825 |
| Operations and support | 3609 | 2235 | 8782 | 6568 |
| Product development | 2470 | 1520 | 5870 | 4770 |
| General and administrative | 1610 | 1294 | 4051 | 3952 |
| Total stock compensation expense | $10748 | $6954 | $25985 | $21115 |

---

**(7) Income Taxes** 

A full valuation allowance has been established against our net U.S. federal and state deferred tax assets and foreign deferred tax assets, including net operating loss carryforwards.

The Company had less than $0.1 million of benefit for income taxes for the three and nine months ended September 30, 2025, and less than $0.1 million of provision for income taxes for the three and nine months ended September 30, 2024. This estimated annual effective tax rate of less than 0.1% differs from the U.S. federal statutory rate primarily due to the effects of certain permanent items, foreign tax rate differences, and increases in the valuation allowance against deferred tax assets.

------

[<u>**Table of Contents**</u>](#toc_page)

**(8) Net Loss Per Share Attributable to Common Stockholders** 

The Company computes net loss per share of Class A common stock, Class B common stock and participating securities using the two-class method. Basic and diluted EPS are the same for each class of common stock and participating securities because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net loss | $(11597) | $(10199) | $(53110) | $(40507) |
| Net (loss) income attributable to noncontrolling interest |  |  | (1) | 5 |
| Net loss attributable to common stockholders | $(11597) | $(10199) | $(53109) | $(40512) |
| Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted, of Class A and Class B common stock | 50920588 | 49282164 | 50653997 | 48901475 |
| Net loss per share attributable to common stockholders, basic and diluted, of Class A and Class B common stock | $(0.23) | $(0.21) | $(1.05) | $(0.83) |

---

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect, or issuance of such shares is contingent upon the occurrence of an event:

---

| | | |
|:---|:---|:---|
|  | **September 30,** | **September 30,** |
|  | **2025** | **2024** |
| Stock options outstanding | 1535777 | 2104032 |
| Unvested restricted stock units | 3059164 | 2494772 |
| Unvested performance restricted stock units | 468715 | 272515 |
| Shares reserved for charitable contribution | 100663 | 181195 |
| 2027 Notes | 1529157 | 5123624 |
| 2030 Notes | 5312375 |  |
| Total shares | 12005851 | 10176138 |

---

**(9) Debt Commitments and Contingencies** 

*2030 Convertible Notes*

In June 2025, we issued $250.0 million aggregate principal amount of 0.75% convertible senior notes due in 2030 (the "2030 Notes"), including the exercise in full of the initial purchasers' option to purchase up to an additional $25.0 million principal amount of the 2030 Notes, pursuant to an indenture dated June 12, 2025. The 2030 Notes were sold in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2030 Notes were $241.4 million, net of debt issuance costs. The debt issuance costs are amortized to interest expense using the effective interest rate method.

The 2030 Notes are general unsecured obligations and bear regular interest at 0.75% per annum, payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2025. The 2030 Notes will mature on June 15, 2030, unless earlier repurchased, redeemed, or converted in accordance with their terms prior to such date.

The 2030 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 21.2495 shares of Class A common stock per $1,000 principal amount of 2030 Notes, which is equivalent to an initial conversion price of approximately $47.06 per share of our Class A common stock. The conversion rate is subject to customary adjustments for certain events as described in the indenture governing the 2030 Notes. In addition, following certain corporate events that occur prior to the maturity date of the 2030 Notes or if we deliver a notice of redemption in respect of the 2030 Notes, we will, under certain circumstances, increase the conversion rate of the 2030 Notes for a holder who elects to convert its 2030 Notes in connection with such a corporate event or convert its 2030 Notes called (or deemed called) for redemption in connection with such notice of redemption, as the case may be.

We may redeem for cash all or any portion of the 2030 Notes, at our option, on or after June 20, 2028 if the last reported sale price of our Class A common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the 2030 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

------

[<u>**Table of Contents**</u>](#toc_page)

Holders of the 2030 Notes may convert all or a portion of their 2030 Notes at their option prior to the close of business on the business day immediately preceding March 15, 2030, in multiples of $1,000 principal amounts, only under the following circumstances:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during any calendar quarter commencing after the calendar quarter ending on September 30, 2025 (and only during such calendar quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2030 Notes on each such trading day;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during the five business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of the 2030 Notes for each day of such ten consecutive trading day period was less than 98% of the product of the last reported sale price of our Class A common stock and the applicable conversion rate of the 2030 Notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on a notice of redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date, in which case we may be required to increase the conversion rate for the 2030 Notes so surrendered for conversion in connection with such redemption notice; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on the occurrence of specified corporate events.

On or after March 15, 2030, the 2030 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

In the event of a fundamental change (as defined in the indenture governing the 2030 Notes), subject to certain conditions and limited exceptions, holders of the 2030 Notes may require us to repurchase for cash all or a portion of the 2030 Notes at a price equal to 100% of the principal amount of the 2030 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date.

We accounted for the issuance of the 2030 Notes as a single liability measured at its amortized cost, as no embedded features require bifurcation and recognition as derivatives.

*2027 Convertible Notes*

In February 2022, we issued $287.5 million aggregate principal amount of 1.00% convertible senior notes due in 2027 (the "2027 Notes" and collectively with the 2030 Notes, the "Convertible Notes") pursuant to an indenture dated February 4, 2022. The 2027 Notes were sold in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2027 Notes were $278.2 million, net of debt issuance costs. The debt issuance costs are amortized to interest expense using the effective interest rate method.

The 2027 Notes are unsecured obligations and bear regular interest at 1% per annum, payable on February 1 and August 1 of each year. The 2027 Notes will mature on February 1, 2027 unless repurchased, redeemed, or converted in accordance with their terms prior to such date.

The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 17.8213 shares of Class A common stock per $1,000 principal amount of 2027 Notes, which is equivalent to an initial conversion price of approximately $56.11 per share of our Class A common stock. The conversion rate is subject to customary adjustments for certain events as described in the indenture governing the 2027 Notes. In addition, following certain corporate events that occur prior to the maturity date of the 2027 Notes or if we deliver a notice of redemption in respect of the 2027 Notes, we will, under certain circumstances, increase the conversion rate of the 2027 Notes for a holder who elects to convert its 2027 Notes in connection with such a corporate event or convert its 2027 Notes called (or deemed called) for redemption in connection with such notice of redemption, as the case may be.

We may redeem for cash all or any portion of the 2027 Notes, at our option, on or after February 5, 2025 if the last reported sale price of our Class A common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the 2027 Notes to be redeemed, plus accrued and unpaid interest.

Holders of the 2027 Notes may convert all or a portion of their 2027 Notes at their option prior to November 1, 2026, in multiples of $1,000 principal amounts, only under the following circumstances:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during any calendar quarter commencing after the calendar quarter ending on June 30, 2022 (and only during such quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2027 Notes on each such trading day;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during the five business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of the 2027 Notes for each day of that ten consecutive trading day period was less than 98% of the product of the last reported sale price of our Class A common stock and the applicable conversion rate of the 2027 Notes;

------

[<u>**Table of Contents**</u>](#toc_page)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on a notice of redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, in which case we may be required to increase the conversion rate for the 2027 Notes so surrendered for conversion in connection with such redemption notice; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on the occurrence of specified corporate events.

On or after November 1, 2026, the 2027 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

In the event of a fundamental change (as defined in the indenture governing the 2027 Notes), subject to certain conditions and limited exceptions, holders of the 2027 Notes may require us to repurchase all or a portion of the 2027 Notes at a price equal to 100% of the principal amount of 2027 Notes, plus accrued and unpaid interest.

We accounted for the issuance of the 2027 Notes as a single liability measured at its amortized cost, as no embedded features require bifurcation and recognition as derivatives.

*Partial Repurchase of 2027 Notes* 

We used a portion of the net proceeds from the issuance of the 2030 Notes to repurchase approximately $201.7 million in aggregate principal amount of outstanding 2027 Notes. The total cash paid in connection with this repurchase was approximately $216.7 million, which included approximately $0.7 million to pay the accrued interest through the settlement date and an approximate $14.3 million premium. The repurchase resulted in a $16.4 million loss on debt extinguishment, which included the write-off of $2.1 million of deferred costs related to the 2027 Notes. The loss on debt extinguishment was recorded within Other expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

Following this partial repurchase, approximately $85.8 million aggregate principal amount of the 2027 Notes remain outstanding on our Condensed Consolidated Balance Sheet. The original terms and conditions continue to apply to the remaining 2027 Notes, and the unamortized debt discount and issuance costs related to these notes will continue to accrete to interest expense.

The following table presents the outstanding principal amount and carrying value of the Convertible Notes as of the dates indicated (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|  | **Principal** | **Unamortized Debt Discount** | **Unamortized Debt Issuance Costs** | **Carrying Value** |
| 2027 Notes | $85805 | $(685) | $(53) | $85067 |
| 2030 Notes | 250000 | (7050) | (1074) | 241876 |
| Total | $335805 | $(7735) | $(1127) | $326943 |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Principal** | **Unamortized Debt Discount** | **Unamortized Debt Issuance Costs** | **Carrying Value** |
| 2027 Notes | $287500 | $(3594) | $(278) | $283628 |

---

The annual effective interest rate for the 2027 Notes and the 2030 Notes were approximately 1.6% and 1.4%, respectively. Interest expense related to the Convertible Notes for the periods presented below was as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br>September 30,** | **Three Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Coupon interest | $684 | $718 | $2108 | $2156 |
| Amortization of debt discount | 503 | 431 | 1378 | 1294 |
| Amortization of transaction costs | 87 | 33 | 149 | 100 |
| Total interest expense | $1274 | $1182 | $3635 | $3550 |

---

------

[<u>**Table of Contents**</u>](#toc_page)

The Company estimates the fair value of the Convertible Notes based on quoted market prices in less active markets and is classified as Level 2 in the fair value hierarchy. The following table presents the carrying value and estimated fair value of the Convertible Notes as of the date indicated (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | **Carrying Value** | **Fair Value** | **Carrying Value** | **Fair Value** |
| 2027 Notes<sup>(1)</sup> | $85067 | $102494 | $283628 | $311621 |
| 2030 Notes<sup>(1)</sup> | 241876 | 352300 |  |  |
| Total Convertible Notes | $326943 | $454794 | $283628 | $311621 |

---

(1) As of September 30, 2025 and December 31, 2024, the fair value of the Convertible Notes, as applicable, were measured using Level 2 inputs based on the frequency of trading on our debt at the end of the period.

*Capped Call Transactions*

In connection with the issuance of the 2030 Notes, we entered into capped call transactions (the "Capped Calls") with respect to its Class A common shares with certain financial institutions. The Capped Calls are expected to reduce the potential dilution to our Class A common stock upon any conversion of the 2030 Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted 2030 Notes, as the case may be, with such reduction and/or offset subject to a cap based on a cap price initially equal to $63.35 per share and which is subject to certain adjustments under the terms of the Capped Calls.

We used approximately $17.5 million of the net proceeds from the 2030 Notes to pay the cost of the Capped Calls. These instruments are classified as equity and recorded as a reduction of additional paid-in capital in the Condensed Consolidated Statements of Changes in Stockholders' Equity. The Capped Calls are not accounted for as derivatives and will not be remeasured; they will remain in stockholder's equity until expiration or settlement.

*Purchase of Treasury Stock* 

In conjunction with the 2030 Notes issuance, we purchased 220,994 shares of our Class A common stock in privately negotiated transactions at an average price of $36.20 per share on June 9, 2025. The $8.1 million of treasury stock repurchase costs was funded using a portion of the proceeds of the 2030 Notes and was recorded as a reduction to stockholder's equity in the Condensed Consolidated Statements of Changes in Stockholders' Equity.

*Contingencies* 

The Company from time to time may be subject to various claims and legal proceedings covering a range of matters that arise in the ordinary course of its business activities. In the opinion of the Company, although the outcome of any legal proceedings cannot be predicted with certainty, the ultimate liability of the Company in connection with its legal proceedings is not expected to have a material adverse effect on the Company's financial position or operations.

*Restructuring*

During 2025, the Company initiated a restructuring action to help improve efficiency and align resources by reducing our workforce. During the nine months ended September 30, 2025, the Company incurred $1.5 million for employee termination costs related to the restructuring.

The following table shows the total amount incurred and the liability, which was recorded in accrued expenses in the Condensed Consolidated Balance Sheets, for restructuring-related employee termination benefits as of December 31, 2024 and September 30, 2025 (in thousands):

---

| | |
|:---|:---|
|  | **Employee Termination Benefits** |
| Accrued restructuring costs as of December 31, 2024 | $— |
| Restructuring costs incurred during the nine months ended September 30, 2025 | 1464 |
| Amount paid during the period ended September 30, 2025 | (1148) |
| Accrued restructuring costs as of September 30, 2025 | $316 |

---

The following table shows the total restructuring costs incurred during the three and nine months ended September 30, 2025 and 2024 (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **For the Nine Months Ended September 30,** | **For the Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Sales and marketing | $(27) | $— | $62 | $— |
| Operations and support | (108) |  | 718 |  |
| Product development | 11 |  | 510 |  |
| General and administrative | 32 |  | 174 |  |
| Total restructuring charges | $(92) | $— | $1464 | $— |

---

------

[<u>**Table of Contents**</u>](#toc_page)

*Defined Contribution Plans*

The Company sponsors a defined contribution plan for qualifying employees, including a 401(k) Plan in the United States to which it makes matching contributions of 50% of participating employee contributions up to 6% of eligible income. The Company's total matching contribution to the 401(k) Plan was $0.6 million and $0.6 million for the three months ended September 30, 2025 and 2024, respectively, and was $1.9 million and $1.8 million for the nine months ended September 30, 2025 and 2024, respectively.

**(10) Goodwill and Intangible Assets** 

The following tables summarize the Company's intangible assets (dollars in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|  | **Weighted<br>average<br>amortization<br>period in<br>years** | **Gross<br>carrying<br>amount** | **Accumulated<br>amortization** | **Net<br>carrying<br>amount** |
| Customer Relationships | 15 | $36600 | $9301 | $27299 |
| Trade Names | 10 | 800 | 305 | 495 |
| Developed Technology | 5 | 740 | 597 | 143 |
| Vendor Relationships | 15 | 1254 | 483 | 771 |
| Database | 5 | 2400 | 1830 | 570 |
| Patents | 17 | 157 | 68 | 89 |
| Subtotal intangible assets |  | 41951 | 12584 | 29367 |
| In-place Lease Intangible Asset | 4 | 568 | 534 | 34 |
| Above Market Lease Intangible Asset | 4 | 896 | 841 | 55 |
| Total intangible assets |  | $43415 | $13959 | $29456 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Weighted<br>average<br>amortization<br>period in<br>years** | **Gross<br>carrying<br>amount** | **Accumulated<br>amortization** | **Net<br>carrying<br>amount** |
| Customer Relationships | 15 | $36600 | $7471 | $29129 |
| Trade Names | 10 | 800 | 245 | 555 |
| Developed Technology | 5 | 739 | 507 | 232 |
| Vendor Relationships | 15 | 1263 | 420 | 843 |
| Database | 5 | 2400 | 1470 | 930 |
| Patents | 17 | 157 | 61 | 96 |
| Subtotal intangible assets |  | 41959 | 10174 | 31785 |
| In-place Lease Intangible Asset | 4 | 568 | 433 | 135 |
| Above Market Lease Intangible Asset | 4 | 896 | 677 | 219 |
| Total intangible assets |  | $43423 | $11284 | $32139 |

---

The following table provides a roll forward of the carrying amount of goodwill (in thousands):

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Balance as of January 1: |  |  |
| Gross goodwill | $265760 | $265989 |
| Accumulated impairments | (3074) | (3074) |
| Net goodwill as of January 1 | 262686 | 262915 |
| Goodwill acquired during the year |  |  |
| Impact of foreign exchange | 1084 | (229) |
| Net goodwill as of September 30, 2025 and December 31, 2024: | $263770 | $262686 |

---

As of September 30, 2025 and December 31, 2024, Xometry had $263.8 million and $262.7 million, respectively of goodwill. As of September 30, 2025, $258.0 million was part of Xometry's U.S. operating segment and $5.8 million was part of Xometry's International operating segment. As of December 31, 2024, $258.0 million was part of Xometry's U.S. operating segment and $4.7 million was part of Xometry's International operating segment.

------

[<u>**Table of Contents**</u>](#toc_page)

As of September 30, 2025, estimated amortization expense for intangible assets for the remainder of 2025 and the next five years is: $0.9 million in 2025, $3.2 million in 2026, $2.6 million in 2027, $2.6 million in 2028, $2.6 million in 2029, $2.6 million in 2030 and $15.0 million thereafter.

Amortization expense for the three and nine months ended September 30, 2025 and 2024 was as follows (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Sales and marketing | $770 | $770 | $2310 | 2310 |
| Product development | 30 | 42 | 90 | 126 |
| General and administrative <sup>(1)</sup> | 4 | 4 | 11 | 11 |
| Total | $804 | $816 | $2411 | $2447 |

---

(1) Amortization of the lease-related intangible assets is recorded as operating lease expense in general and administrative.

------

[<u>**Table of Contents**</u>](#toc_page)

 **Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

 *The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. The discussion contains forward-looking statements that are based on the beliefs of management, as well as assumptions made by, and information currently available to, our management. Actual results could differ materially from those discussed in or implied by forward-looking statements as a result of various factors, including those discussed in Part II, Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024. Our historical results are not necessarily indicative of the results that may be expected in the future and our current quarterly results are not necessarily indicative of the results expected for the full year or any other period.* 

**Overview** 

Xometry, Inc. ("Xometry", the "Company", "we", or "our") was incorporated in the State of Delaware in May 2013 and our corporate headquarters is located in North Bethesda, Maryland. Xometry operates a global artificial intelligence ("AI") powered online manufacturing marketplace, a leading North American industrial sourcing platform Thomasnet® and a suite of cloud-based services including Workcenter and Teamspace that are rapidly digitizing the manufacturing industry. Together, these platforms provide manufacturers the critical resources they need to grow their business and make it easy for buyers to create resilient supply chains. Xometry's marketplaces use proprietary AI to help buyers efficiently source custom-manufactured parts and assemblies and attain instant pricing and lead times. The AI enables our rapidly growing network of manufacturers to select the optimal jobs to fill their capacity. Our suite of cloud-based services and our Thomasnet industrial sourcing platform helps manufacturers and industrial service providers grow their businesses using our advertising, marketing and financial services.

We use proprietary technology to enable product designers, engineers, buyers, and supply chain professionals to instantly access the capacity of a global network of manufacturing facilities. The Company's platform makes it possible for buyers to quickly receive pricing, expected lead times, manufacturability feedback and place orders on the Company's platform. The network allows the Company to provide high volumes of unique parts, including custom components and assemblies for its buyers, as well as larger production orders of single parts. Xometry's Teamspace offers enterprise-wide collaboration software that unites engineers, managers and purchasing executives to expedite procurement of custom-manufacturing services. We continue to improve features on Xometry and expand the offering with the launch of Teamspace in Europe in the second quarter of 2025. In the third quarter of 2025, Thomasnet launched a new dynamic ad serving technology platform and began selling on the new platform for new customers. During the fourth quarter of 2025, we launched the new Workcenter mobile application, expanding the functionality of the platform.

Our mission is to accelerate innovation by providing real-time, equitable access to global manufacturing capacity and demand. Our vision is to drive efficiency, sustainability and innovation for industries worldwide by lowering the barriers to entry to the manufacturing ecosystem.

Our business benefits from a virtuous network effect, because adding buyers to our platform generates greater demand on our marketplace which in turn attracts more suppliers to the platform, allowing us to rapidly scale and increase the number of manufacturing processes offered on our platform. In order to continue to meet the needs of buyers and remain highly competitive, we expect to continue to add suppliers to our platform that have new and innovative manufacturing processes. Thus, our platform is unbounded by the in-house manufacturing capacity and processes of our current suppliers.

We define "buyers" as individuals who have placed an order to purchase custom-manufactured, on-demand parts or assemblies on our marketplace. Our buyers include engineers, product designers, procurement and supply chain personnel, entrepreneurs, technicians and business owners from small businesses to Fortune 500 companies. We define "accounts" as an individual entity, such as a sole proprietor with a single buyer or corporate entities with multiple buyers, having purchased at least one part on our marketplace. We define "suppliers" as individuals or businesses who have been approved by us to either manufacture a product on our marketplace for a buyer or have utilized our supplier services, including our financial services or the purchase of tools and materials.

The majority of our revenue is derived from the sale of part(s) and assemblies to our customers on our marketplace, which we refer to as marketplace revenue. The suppliers on our platform offer a diversified and expanding mix of manufacturing processes. These manufacturing processes include computer numerical control ("CNC") manufacturing, sheet metal forming, sheet cutting, 3D printing (including fused

------

[<u>**Table of Contents**</u>](#toc_page)

deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion and lubricant sublayer photo-curing), die casting, stamping, injection molding, urethane casting, tube cutting, tube bending, as well as finishing services, rapid prototyping and high-volume production. Xometry's extensible technology platform allows the Company to add new technologies and processes to gain more wallet share with our buyers. We enable buyers to source these processes to meet complex and specific design and order needs across several industries, including Aerospace, Industrial, Medical Devices, Automotive, Consumer Goods, Defense, Government, Energy, Education and Robotics.

We empower suppliers to grow their manufacturing businesses and improve machine utilization by providing access to an extensive, diverse base of buyers. We also offer suppliers supporting services to meet their unique needs. The Thomasnet product sourcing and supplier discovery digital platform provides access to in-depth profiles of 500,000 North American suppliers. Thomas' suite of advertising services provides suppliers with tailored marketing campaigns to maximize their visibility and enhance engagement with potential buyers. Thomas' in-house digital marketing agency, Thomas Marketing Services, offers a range of essential digital marketing services to generate leads and boost the awareness and reach of suppliers. In addition, our supplier services include financial service products to facilitate faster payments and a cloud-based manufacturing execution system ("Workcenter") to help suppliers optimize their productivity. Workcenter digitally enables qualifying and on-boarding suppliers and allows suppliers to manage all their Xometry and non-Xometry work and provides for expedited payment terms in support of their business.

Unfavorable conditions in the economy both in the United States and abroad may negatively affect the growth of our business and our results of operations. For example, macroeconomic events, fluctuations in inflation and interest rates, volatile market conditions, impacts from tariffs, the ongoing U.S. government shutdown, the Russia-Ukraine war, conflict in the Middle East and other geopolitical tensions, have led to economic uncertainty globally. Historically, during periods of economic uncertainty and downturns, businesses may slow spending on information technology and manufacturing, which may impact our business and our customers' businesses.

The effect of macroeconomic conditions may not be fully reflected in our results of operations until future periods. If, however, economic uncertainty increases or the global economy worsens, our business, financial condition and results of operations may be harmed. For further discussion of the potential impacts of macroeconomic events on our business, financial condition, and operating results, see the section titled "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Convertible Notes Transactions**

In June 2025, we issued $250.0 million aggregate principal amount of 0.75% Convertible Senior Notes due 2030. The net proceeds from the issuance of the 2030 Notes were approximately $241.4 million, net of debt issuance costs. We used a portion of the net proceeds to (i) repurchase a portion of our outstanding 1.00% convertible senior notes due 2027, (ii) enter into capped call transactions and (iii) repurchase shares of our Class A common stock. Refer to Note 9, *Debt Commitments and Contingencies* for our consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

**Restructuring**

During 2025, we initiated restructuring actions to help improve efficiency and align resources by reducing our workforce by approximately 5%. The workforce reduction focused on realigning our staffing levels to help us meet the current and future objectives of our business. For the nine months ended September 30, 2025, we incurred $1.5 million for employee termination costs related to our restructuring. Refer to Note 9, *Debt Commitments and Contingencies—Restructuring* for our consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

**U.S. Tax Legislation**

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted into law in the United States. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions that were originally enacted in the 2017 Tax Cuts and Jobs Act and were set to expire on December 31, 2025, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Company is currently assessing the OBBBA's impact on its consolidated financial statements. Based on our preliminary assessment, we do not believe the legislation will have a material impact on our condensed financial statements.

------

[<u>**Table of Contents**</u>](#toc_page)

**Key Marketplace Operational and Business Metrics** 

In addition to the measures presented in our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, we use the following key operational and business metrics to help us evaluate our marketplace business, measure our performance, identify trends affecting our business, formulate business plans and develop forecasts, and make strategic decisions:

***Active Buyers*** 

We define Active Buyers as the number of buyers who have made at least one purchase on our marketplace during the last twelve months. An increase or decrease in the number of Active Buyers is a key indicator of our ability to attract, retain and engage buyers on our platform.

Active Buyers has consistently grown over time. The number of Active Buyers on our platform reached 78,282 as of September 30, 2025, up 21% from 64,851 as of September 30, 2024. The key drivers of Active Buyer growth are continued account and buyer engagement and the success of our strategy to attract new buyers.

![img31789825_0.jpg](img31789825_0.jpg)

------

[<u>**Table of Contents**</u>](#toc_page)

***Percentage of Revenue from Existing Accounts*** 

We define an existing account as an account where at least one buyer has made a purchase on our marketplace. We believe the efficiency and transparency of our business model leads to increasing account stickiness and spend over time. Buyers can utilize our marketplace for both one-off and recurring manufacturing opportunities. For example, a buyer may choose to utilize our marketplace's CNC manufacturing processes to manufacture a discrete component for a prototype, and then may choose to later use our marketplace to mass produce that same component. A buyer may also recommend our marketplace to other engineers within their organizations who are designing other products and who may use an entirely different set of manufacturing processes, deepening our reach and stickiness with an account.

For the quarter ended September 30, 2025, 98% of our revenue was generated from existing accounts. We believe the repeat purchase activity from existing accounts reflects the underlying strength of our business and provides us with substantial revenue visibility and predictability.

![img31789825_1.jpg](img31789825_1.jpg)

------

[<u>**Table of Contents**</u>](#toc_page)

***Accounts with Last Twelve-Month Spend of at Least $50,000*** 

Accounts with Last Twelve-Month, or LTM, Spend of at Least $50,000 means an account that has spent at least $50,000 on our marketplace in the most recent twelve-month period. We view the acquisition of an account as a foundation for the addition of long-term buyers to our marketplace. Once an account joins our platform, we aim to expand the relationship and increase engagement and spending activities from that account over time. The number of accounts with LTM Spend of at Least $50,000 on our platform reached 1,724 as of September 30, 2025, up 14% from 1,506 as of September 30, 2024.

![img31789825_2.jpg](img31789825_2.jpg)

------

[<u>**Table of Contents**</u>](#toc_page)

***Adjusted EBITDA*** 

We define Adjusted EBITDA as net loss, adjusted for interest expense, interest and dividend income, other expenses, and certain other non-cash or non-recurring items impacting net loss from time to time, principally comprised of depreciation and amortization, amortization of lease intangible, (benefit) provision for income taxes, stock-based compensation, payroll tax expense related to stock-based compensation, charitable contributions of common stock, income from unconsolidated joint venture, impairment of assets, restructuring charges, and acquisition and other adjustments not reflective of our ongoing business, such as adjustments related to purchase accounting, the revaluation of contingent consideration, transaction costs and executive severance. Adjusted EBITDA is a performance measure that we use to assess our operating performance and the operating leverage in our business. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA for a period by revenue for the same period.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net loss | $(11597) | $(10199) | $(53110) | $(40507) |
| Add (deduct): |  |  |  |  |
| Interest expense, interest and dividend income and other expenses<sup>(1)</sup> | 775 | (1150) | 16939 | (3647) |
| Depreciation and amortization | 5000 | 3213 | 13741 | 9622 |
| Amortization of lease intangible | 180 | 180 | 540 | 540 |
| (Benefit) provision for income taxes | (17) | 30 | (25) | 20 |
| Stock-based compensation | 10748 | 6954 | 25985 | 21115 |
| Payroll tax expense related to stock-based compensation | 366 | 96 | 2100 | 876 |
| Acquisition and other |  |  | 927 | 686 |
| Charitable contribution of common stock | 950 | 406 | 2080 | 1063 |
| Income from unconsolidated joint venture | (220) | (162) | (544) | (493) |
| Impairment of assets | 49 |  | 49 |  |
| Restructuring charges | (92) |  | 1464 |  |
| Adjusted EBITDA | $6142 | $(632) | $10146 | $(10725) |

---

(1) Includes loss on debt extinguishment.

For the three months ended September 30, 2025, Adjusted EBITDA was $6.1 million, as compared to Adjusted EBITDA of $(0.6) million for the same quarter in 2024. For the three months ended September 30, 2025, Adjusted EBITDA Margin was 3.4% of revenue, as compared to (0.4)% of revenue for the same quarter in 2024.

For the nine months ended September 30, 2025, Adjusted EBITDA was $10.1 million, as compared to Adjusted EBITDA of $(10.7) million for the same period in 2024. For the nine months ended September 30, 2025, Adjusted EBITDA Margin was 2.1% of revenue, as compared to (2.7)% of revenue for the same period in 2024. The increase in Adjusted EBITDA was driven primarily by increased operating efficiencies as we continue to grow our revenue and margins faster than our expenses.

***Non-GAAP Net Income (Loss)*** 

We define Non-GAAP net income (loss), as net loss adjusted for depreciation and amortization, stock-based compensation, payroll tax expense related to stock-based compensation, amortization of lease intangible, amortization of deferred costs on convertible notes, gain on sale of property and equipment, charitable contributions of common stock, lease termination, impairment of assets, restructuring charges, loss on debt extinguishment and acquisition and other adjustments not reflective of our ongoing business, such as adjustments related to purchase accounting, the revaluation of contingent consideration, transaction costs and executive severance.

------

[<u>**Table of Contents**</u>](#toc_page)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **For the Three Months<br>Ended September 30,** | **For the Three Months<br>Ended September 30,** | **For the Nine Months<br>Ended September 30,** | **For the Nine Months<br>Ended September 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **<u>Non-GAAP Net Income (Loss):</u>** |  |  |  |  |
| Net loss | $(11597) | $(10199) | $(53110) | $(40507) |
| Add (deduct): |  |  |  |  |
| Depreciation and amortization | 5000 | 3213 | 13741 | 9622 |
| Stock-based compensation | 10748 | 6954 | 25985 | 21115 |
| Payroll tax expense related to stock-based compensation | 366 | 96 | 2100 | 876 |
| Amortization of lease intangible | 180 | 180 | 540 | 540 |
| Amortization of deferred costs on convertible notes | 590 | 464 | 1527 | 1394 |
| Acquisition and other | - | - | 926 | 686 |
| Gain on sale of property and equipment | - | - | - | (23) |
| Charitable contribution of common stock | 950 | 406 | 2080 | 1063 |
| Lease termination | 16 | - | (14) | - |
| Impairment of assets | 49 | - | 49 | - |
| Restructuring charges | (92) | - | 1464 | - |
| Loss on debt extinguishment | - | - | 16430 | - |
| **Non-GAAP Net Income (Loss)** | $6210 | $1114 | $11718 | $(5234) |

---

For the three months ended September 30, 2025, Non-GAAP net income was $6.2 million, as compared to Non-GAAP net income of $1.1 million for the same quarter in 2024. For the quarter ended September 30, 2025, Non-GAAP net income was 3.4% of revenue, as compared to 0.8% of revenue for the same quarter in 2024.

For the nine months ended September 30, 2025, Non-GAAP net income was $11.7 million, as compared to Non-GAAP net loss of $(5.2) million for the same period in 2024. For the nine months ended September 30, 2025, Non-GAAP net income (loss) was 2.4% of revenue, as compared to (1.3)% of revenue for the same period in 2024.

Adjusted EBITDA and Non-GAAP net income (loss) are non-GAAP financial measures that we use, in addition to our GAAP financial measures, to evaluate our business. We have included Adjusted EBITDA and Non-GAAP net income (loss) in this filing because they are key measures used by our management to evaluate our operating performance. Accordingly, we believe that Adjusted EBITDA and Non-GAAP net income (loss) provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management team and board of directors. Our calculation of Adjusted EBITDA and Non-GAAP net income (loss) may differ from similarly titled non-GAAP measures, if any, reported by our peer companies and therefore may not serve as an accurate basis of comparison among companies. Adjusted EBITDA and Non-GAAP net income (loss) should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

**Components of Results of Operations** 

***Revenue*** 

Our marketplace revenue is primarily comprised of sales of parts and assemblies to customers through our platform. Buyers purchase specialized CNC manufacturing, sheet metal manufacturing, 3D printing, injection molding, urethane casting, tube cutting, tube bending and finishing services. Customer purchases range from rapid prototyping of single parts to high-volume production on our marketplace. These products are primarily manufactured by our network of suppliers.

Supplier services revenue includes the sale of marketing and advertising services, and to a lesser extent financial service products and SaaS-based solutions.

***Cost of Revenue*** 

Marketplace cost of revenue primarily consists of the cost to us of the products that are manufactured or produced by us or our suppliers for delivery to buyers on our platform, internal and external production costs, shipping costs and certain internal depreciation. We expect cost of revenue to increase in absolute dollars to the extent our revenue increases and transaction volume increases. As we grow and add suppliers to our platform, we are able to improve our pricing efficiency, and we expect cost of revenue to decline as a percentage of revenue over time.

Cost of revenue for supplier services primarily consists of internal and external production costs and website hosting.

------

[<u>**Table of Contents**</u>](#toc_page)

***Gross Profit*** 

Gross profit, or revenue less cost of revenue, is primarily affected by the growth of our revenue. Our gross profit margin is primarily affected by the size of our supplier network and the efficiency of our pricing and will benefit from increasing the use of existing supplier services and the variety of supplier services offerings over time.

***Operating Expenses*** 

Our operating expenses consist of sales and marketing, operations and support, product development, general and administrative functions and impairment of assets.

***Sales and Marketing*** 

Sales and marketing expenses are expensed as incurred and include the costs of our digital marketing strategies, branding costs and other advertising costs, certain depreciation and amortization expense, contract acquisition costs and compensation expenses, including stock-based compensation, for our sales and marketing employees. We intend to continue to invest in our sales and marketing capabilities in the future to continue to increase our brand awareness, add new accounts and further penetrate existing accounts. We expect sales and marketing expense to increase in absolute dollars in the future as we grow our business, though in the near-term sales and marketing expenses may fluctuate from period to period based on the timing of our investments in our sales and marketing functions as these investments may vary in scope and scale over future periods.

***Operations and Support*** 

Operations and support expenses are the costs we incur in support of the buyers and suppliers on our platform which are provided by phone, email and chat for purposes of resolving buyer and suppliers related matters. These costs primarily consist of compensation expenses of the support staff, including stock-based compensation, restructuring charges, certain depreciation and amortization expense and software costs used in delivering buyer and suppliers services. We expect operations and support expense to increase in absolute dollars in the future, though in the near term operations and support expenses may fluctuate from period to period based on total revenue levels and the timing of our investments in our operations and support functions as these investments may vary in scope and scale over future periods.

***Product Development*** 

Product development costs that are not eligible for capitalization are expensed as incurred. These costs primarily consist of compensation expenses, including stock-based compensation expenses to our employees performing these functions, restructuring charges and certain depreciation and amortization expense. We expect product development expense to increase in absolute dollars in the future, though in the near-term product development expenses may fluctuate from period to period based on total revenue levels and the timing of our investments in our product development functions as these investments may vary in scope and scale over future periods.

***General and Administrative*** 

General and administrative expenses primarily consist of compensation expenses, including stock-based compensation expenses, for executive, finance, legal and other administrative personnel, professional service fees, restructuring charges and certain depreciation and amortization expense. We expect general and administrative expenses to fluctuate as a result of operating as a public company.

***Other (Expenses) Income*** 

*Interest Expense* 

Interest expense consists of interest incurred on our outstanding borrowings under our outstanding convertible notes or other borrowings.

*Interest and Dividend Income*

Interest and dividend income consists of interest and dividends on our cash, cash equivalents and marketable securities.

*Other Expenses*

Other expenses consist primarily of loss on debt extinguishment, realized foreign exchange gains and/or losses, non-income based taxes and other expenses.

*Income from Unconsolidated Joint Venture* 

Income from unconsolidated joint venture consists of our share of the joint venture's income.

------

[<u>**Table of Contents**</u>](#toc_page)

**Results of Operations** 

**Comparison of the Three Months Ended September 30, 2025 and 2024** 

The following table sets forth our unaudited statements of operations data for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
|  | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** |
| Revenue | $180715 | $141698 |
| Cost of revenue | 108686 | 85873 |
| Gross profit | 72029 | 55825 |
| Operating expenses: |  |  |
| Sales and marketing | 32649 | 27204 |
| Operations and support | 18403 | 14698 |
| Product development | 12524 | 9344 |
| General and administrative | 19463 | 16060 |
| Impairment of assets | 49 |  |
| Total operating expenses | 83088 | 67306 |
| Loss from operations | (11059) | (11481) |
| Other (expenses) income: |  |  |
| Interest expense | (1278) | (1187) |
| Interest and dividend income | 2139 | 2781 |
| Other expenses | (1636) | (444) |
| Income from unconsolidated joint venture | 220 | 162 |
| Total other (expenses) income | (555) | 1312 |
| Loss before income taxes | (11614) | (10169) |
| Benefit (provision) for income taxes | 17 | (30) |
| Net loss | (11597) | (10199) |
| Net loss attributable to noncontrolling interest |  |  |
| Net loss attributable to common stockholders | $(11597) | $(10199) |

---

------

[<u>**Table of Contents**</u>](#toc_page)

The following table sets forth our unaudited statements of operations data expressed as a percentage of total revenue for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
|  | **2025** | **2024** |
| Revenue | 100.0% | 100.0% |
| Cost of revenue | 60.1% | 60.6% |
| Gross profit | 39.9% | 39.4% |
| Operating expenses: |  |  |
| Sales and marketing | 18.1% | 19.2% |
| Operations and support | 10.2% | 10.4% |
| Product development | 6.9% | 6.6% |
| General and administrative | 10.8% | 11.3% |
| Impairment of assets | 0.0% | 0.0% |
| Total operating expenses | 46.0% | 47.5% |
| Loss from operations | (6.1)% | (8.1)% |
| Other (expenses) income: |  |  |
| Interest expense | (0.7)% | (0.8)% |
| Interest and dividend income | 1.2% | 2.0% |
| Other expenses | (0.9)% | (0.3)% |
| Income from unconsolidated joint venture | 0.1% | 0.1% |
| Total other (expenses) income | (0.3)% | 1.0% |
| Loss before income taxes | (6.4)% | (7.1)% |
| Benefit (provision) for income taxes | 0.0% | 0.0% |
| Net loss | (6.4)% | (7.1)% |
| Net loss attributable to noncontrolling interest | 0.0% | 0.0% |
| Net loss attributable to common stockholders | (6.4)% | (7.1)% |

---

The following tables present our disaggregated revenue and cost of revenue. Revenue from our marketplace primarily reflects the sales of parts and assemblies on our platform. Revenue from supplier services primarily includes the sale of advertising and to a lesser extent financial service products and SaaS products.

Revenue and cost of revenue is presented in the following tables for the three months ended September 30, 2025 and 2024 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **For the Three Months<br>Ended September 30,** | **For the Three Months<br>Ended September 30,** |
|  | **2025** | **2024** |
| **Marketplace** |  |  |
| Revenue | $166592 | $126965 |
| Cost of revenue | 107086 | 84347 |
| Gross Profit | $59506 | $42618 |
| Gross Margin | 35.7% | 33.6% |
| **Supplier services** |  |  |
| Revenue | $14123 | $14733 |
| Cost of revenue | 1600 | 1526 |
| Gross Profit | $12523 | $13207 |
| Gross Margin | 88.7% | 89.6% |

---

***Revenue*** 

Total revenue increased $39.0 million, or 28%, from $141.7 million for the three months ended September 30, 2024 to $180.7 million for the three months ended September 30, 2025. This growth was a result of an increase in marketplace revenue, partially offset by a decrease in supplier services revenue. Marketplace revenue increased $39.6 million, or 31%, from $127.0 million for the three months ended September 30, 2024 to $166.6 million for the three months ended September 30, 2025. The increase in marketplace revenue was primarily due to increased buyer activity on the platform, particularly with respect to enterprise customers, for the three months ended September 30, 2025 as compared to the prior year period.

------

[<u>**Table of Contents**</u>](#toc_page)

Supplier services revenue decreased $0.6 million, or 4% from $14.7 million for the three months ended September 30, 2024 to $14.1 million for the three months ended September 30, 2025. The decrease in revenue was due to reductions in Thomas advertising and marketing services and to a lesser extent a decrease in Thomas non-core services partly offset by growth in financial services.

Total revenue for the three months ended September 30, 2025 and 2024 was $151.1 million and $117.6 million, respectively, for the U.S. operating segment and $29.6 million and $24.1 million, respectively, for the International operating segment.

***Cost of Revenue*** 

Total cost of revenue increased $22.8 million, or 27%, from $85.9 million for the three months ended September 30, 2024 to $108.7 million for the three months ended September 30, 2025. This increase was primarily the result of an increase in marketplace cost of revenue. Total cost of revenue from marketplace and supplier services for the three months ended September 30, 2025 was $107.1 million and $1.6 million, respectively, as compared to $84.3 million and $1.5 million, respectively, for the three months ended September 30, 2024.

Marketplace cost of revenue was driven by order growth and increased activity on our marketplace.

***Gross Profit and Margin*** 

Gross profit increased $16.2 million, or 29%, from $55.8 million for the three months ended September 30, 2024 to $72.0 million for the three months ended September 30, 2025. The increase in gross profit was primarily due to increases in revenue from marketplace and improved marketplace gross margins as compared to the prior year period.

Total gross margin was 39.9% for the three months ended September 30, 2025 as compared to 39.4% for the three months ended September 30, 2024. The increase was primarily driven by higher marketplace gross margin as compared to the prior period.

Gross margin for marketplace was 35.7% for the three months ended September 30, 2025, as compared to 33.6% for the three months ended September 30, 2024. The improvement was due largely to our AI-driven platform and expanding network of active suppliers which optimizes pricing to buyers and suppliers.

Gross margin for our supplier services was 88.7% for the three months ended September 30, 2025, as compared to 89.6% for the three months ended September 30, 2024.

***Operating Expenses*** 

*Sales and Marketing* 

Sales and marketing expense increased $5.4 million, or 20%, from $27.2 million for the three months ended September 30, 2024 to $32.6 million for the three months ended September 30, 2025, primarily due to increases in consulting expenses and employee compensation costs, including stock-based compensation and benefit costs. As a percent of total revenue, sales and marketing expenses decreased to 18.1% for the three months ended September 30, 2025 from 19.2% for the three months ended September 30, 2024.

Advertising expense decreased 1.9%, from $9.4 million for the three months ended September 30, 2024 to $9.2 million for the three months ended September 30, 2025 primarily due to decreased marketplace advertising.

*Operations and Support* 

Operations and support expense increased $3.7 million, or 25%, from $14.7 million for the three months ended September 30, 2024 to $18.4 million for the three months ended September 30, 2025, primarily due to increases in stock-based compensation, consulting expenses and employee compensation and benefit costs. As a percent of total revenue, operations and support expenses decreased to 10.2% for the three months ended September 30, 2025 from 10.4% for the three months ended September 30, 2024.

*Product Development* 

Product development expense increased $3.2 million, or 34%, from $9.3 million for the three months ended September 30, 2024 to $12.5 million for the three months ended September 30, 2025, primarily as a result of an increase in amortization expense related to capitalized internal-use software development costs, increases in stock-based compensation and software costs. As a percent of total revenue, product development expenses increased to 6.9% for the three months ended September 30, 2025 as compared to 6.6% for the three months ended September 30, 2024.

*General and Administrative* 

General and administrative expense increased $3.4 million, or 21%, from $16.1 million for the three months ended September 30, 2024 to $19.5 million for the three months ended September 30, 2025, primarily due to increases in reserves for bad debt, the cost of charitable contributions of Class A common stock and consulting costs. As a percent of total revenue, general and administrative expenses decreased to 10.8% for the three months ended September 30, 2025 from 11.3% for the three months ended September 30, 2024.

------

[<u>**Table of Contents**</u>](#toc_page)

***Other Income (Expenses)***

*Interest Expense* 

Interest expense increased $0.1 million, or 8%, from $1.2 million for the three months ended September 30, 2024 to $1.3 million for the three months ended September 30, 2025, primarily due to interest expense on the 2030 Notes, offset by the decrease in interest expense due to the partial repurchase of the 2027 Notes.

*Interest and Dividend Income*

Interest and dividend income decreased $0.6 million, or 23%, from $2.8 million for the three months ended September 30, 2024 to $2.1 million for the three months ended September 30, 2025. The decrease was primarily due to lower investment in the money market account as the Company funds ongoing operations.

*Other Expenses* 

Other expenses increased by $1.2 million, from $0.4 million for the three months ended September 30, 2024 to $1.6 million for the three months ended September 30, 2025. The increase was primarily due to higher non-income based taxes.

*Income from Unconsolidated Joint Venture* 

Income from unconsolidated joint venture remained flat at $0.2 million for the three months ended September 30, 2025 and 2024.

*Additional Segment Considerations* 

Segment Adjusted EBITDA from our U.S. reportable segment for the three months ended September 30, 2025 and 2024 was $10.3 million and $1.4 million, respectively. Segment Adjusted EBITDA from our International reportable segment for the three months ended September 30, 2025 and 2024 was $(4.2) million and $(2.0) million, respectively.

Refer to Note 5, *Segments* as we changed our measure of segment profit or loss in 2024 to Segment Adjusted EBITDA and recast prior year data.

**Comparison of the Nine Months Ended September 30, 2025 and 2024** 

The following table sets forth our unaudited statements of operations data for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** |
| Revenue | $494234 | $396983 |
| Cost of revenue | 300698 | 240379 |
| Gross profit | 193536 | 156604 |
| Operating expenses: |  |  |
| Sales and marketing | 88866 | 81891 |
| Operations and support | 53225 | 42918 |
| Product development | 34703 | 28952 |
| General and administrative | 53433 | 47470 |
| Impairment of assets | 49 |  |
| Total operating expenses | 230276 | 201231 |
| Loss from operations | (36740) | (44627) |
| Other (expenses) income: |  |  |
| Interest expense | (3648) | (3564) |
| Interest and dividend income | 6591 | 8275 |
| Other expenses | (19882) | (1064) |
| Income from unconsolidated joint venture | 544 | 493 |
| Total other (expenses) income | (16395) | 4140 |
| Loss before income taxes | (53135) | (40487) |
| Benefit (provision) for income taxes | 25 | (20) |
| Net loss | (53110) | (40507) |
| Net (loss) income attributable to noncontrolling interest | (1) | 5 |
| Net loss attributable to common stockholders | $(53109) | $(40512) |

---

------

[<u>**Table of Contents**</u>](#toc_page)

The following table sets forth our unaudited statements of operations data expressed as a percentage of total revenue for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
| Revenue | 100.0% | 100.0% |
| Cost of revenue | 60.8% | 60.6% |
| Gross profit | 39.2% | 39.4% |
| Operating expenses: |  |  |
| Sales and marketing | 18.0% | 20.6% |
| Operations and support | 10.8% | 10.8% |
| Product development | 7.0% | 7.3% |
| General and administrative | 10.8% | 12.0% |
| Impairment of assets | 0.0% | 0.0% |
| Total operating expenses | 46.6% | 50.7% |
| Loss from operations | (7.4)% | (11.3)% |
| Other (expenses) income: |  |  |
| Interest expense | (0.7)% | (0.9)% |
| Interest and dividend income | 1.3% | 2.1% |
| Other expenses | (4.0)% | (0.3)% |
| Income from unconsolidated joint venture | 0.1% | 0.1% |
| Total other (expenses) income | (3.3)% | 1.0% |
| Loss before income taxes | (10.7)% | (10.3)% |
| Benefit (provision) for income taxes | 0.0% | 0.0% |
| Net loss | (10.7)% | (10.3)% |
| Net (loss) income attributable to noncontrolling interest | 0.0% | 0.0% |
| Net loss attributable to common stockholders | (10.7)% | (10.3)% |

---

The following tables present our disaggregated revenue and cost of revenue. Revenue from our marketplace primarily reflects the sales of parts and assemblies on our platform. Revenue from supplier services primarily includes the sale of advertising and to a lesser extent financial service products and SaaS products.

Revenue and cost of revenue is presented in the following tables for the nine months ended September 30, 2025 and 2024 (in thousands):

---

| | | |
|:---|:---|:---|
|  | **For the Nine Months<br>Ended September 30,** | **For the Nine Months<br>Ended September 30,** |
|  | **2025** | **2024** |
| **Marketplace** |  |  |
| Revenue | $451168 | $351438 |
| Cost of revenue | 295891 | 235278 |
| Gross Profit | $155277 | $116160 |
| Gross Margin | 34.4% | 33.1% |
| **Supplier services** |  |  |
| Revenue | $43066 | $45545 |
| Cost of revenue | 4807 | 5101 |
| Gross Profit | $38259 | $40444 |
| Gross Margin | 88.8% | 88.8% |

---

***Revenue*** 

Total revenue increased $97.3 million, or 24%, from $397.0 million for the nine months ended September 30, 2024 to $494.2 million for the nine months ended September 30, 2025. This growth was a result of an increase in marketplace revenue, partially offset by a decrease in supplier services revenue. Marketplace revenue increased $99.7 million, or 28%, from $351.4 million for the nine months ended September 30, 2024 to $451.2 million for the nine months ended September 30, 2025. The increase in marketplace revenue was primarily due to increased buyer activity on the platform, particularly with respect to enterprise customers, for the nine months ended September 30, 2025 as compared to the prior year period.

------

[<u>**Table of Contents**</u>](#toc_page)

Supplier services revenue decreased $2.5 million, or 5%, from $45.5 million for the nine months ended September 30, 2024 to $43.1 million for the nine months ended September 30, 2025. The decrease in revenue was due to reductions in Thomas advertising and marketing services and to a lesser extent a decrease in Thomas non-core services partly offset by growth in financial services.

Total revenue for the nine months ended September 30, 2025 and 2024, was $414.6 million and $333.1 million, respectively, for the U.S. operating segment, and $79.6 million and $63.9 million, respectively, for the International operating segment.

***Cost of Revenue*** 

Total cost of revenue increased $60.3 million, or 25%, from $240.4 million for the nine months ended September 30, 2024 to $300.7 million for the nine months ended September 30, 2025. This increase was primarily the result of an increase in marketplace cost of revenue. Total cost of revenue from marketplace and supplier services for the nine months ended September 30, 2025 was $295.9 million and $4.8 million, respectively, as compared to $235.3 million and $5.1 million, respectively, for the nine months ended September 30, 2024.

Marketplace cost of revenue was driven by increased payments to suppliers on our platform due to order growth and increased activity on our marketplace.

***Gross Profit and Margin*** 

Gross profit increased $36.9 million, or 24%, from $156.6 million for the nine months ended September 30, 2024 to $193.5 million for the nine months ended September 30, 2025. The increase in gross profit was primarily due to increases in revenue from marketplace and improved marketplace gross margins as compared to the prior year period.

Total gross margin was 39.2% for the nine months ended September 30, 2025 as compared to 39.4% for the nine months ended September 30, 2024. The decrease is primarily driven by faster growth and associated mix shift to marketplace revenue which has a lower gross margin than supplier services.

Gross margin for marketplace was 34.4% for the nine months ended September 30, 2025, as compared to 33.1% for the nine months ended September 30, 2024. The improvement was due largely to our AI-driven platform and expanding network of active suppliers which optimizes pricing to buyers and suppliers.

Gross margin for our supplier services remained flat at 88.8% for the nine months ended September 30, 2025 and 2024.

***Operating Expenses*** 

*Sales and Marketing* 

Sales and marketing expense increased $7.0 million, or 9%, from $81.9 million for the nine months ended September 30, 2024 to $88.9 million for the nine months ended September 30, 2025, primarily due to increases in consulting expenses and employee compensation costs, including stock-based compensation and benefit costs. These increases were partially offset by a reduction in marketing and advertising expense. As a percent of total revenue, sales and marketing expenses decreased to 18.0% for the nine months ended September 30, 2025 from 20.6% for the nine months ended September 30, 2024.

Advertising expense decreased 5%, from $26.5 million for the nine months ended September 30, 2024 to $25.3 million for the nine months ended September 30, 2025 primarily due to decreased marketplace advertising.

*Operations and Support* 

Operations and support expense increased $10.3 million, or 24%, from $42.9 million for the nine months ended September 30, 2024 to $53.2 million for the nine months ended September 30, 2025, primarily due to the hiring of additional operations and support employees and their compensation costs including stock-based compensation, an increase in consulting costs, and severance costs related to the restructuring. As a percent of total revenue, operations and support expenses remained flat at 10.8% for the nine months ended September 30, 2025 and 2024.

*Product Development* 

Product development expense increased $5.8 million, or 20%, from $29.0 million for the nine months ended September 30, 2024 to $34.7 million for the nine months ended September 30, 2025, primarily as a result of increases in amortization expense related to capitalized internal-use software development costs, increases in stock-based compensation, software costs, consulting costs and severance costs related to restructuring. As a percent of total revenue, product development expenses decreased to 7.0% for the nine months ended September 30, 2025 from 7.3% for the nine months ended September 30, 2024.

------

[<u>**Table of Contents**</u>](#toc_page)

*General and Administrative* 

General and administrative expense increased $6.0 million, or 13%, from $47.5 million for the nine months ended September 30, 2024 to $53.4 million for the nine months ended September 30, 2025. The increase was primarily driven by an increase in reserves for bad debt, the cost of charitable contributions of Class A common stock, software costs, consulting costs, compensation costs including stock-based compensation and severance costs related to restructuring. These increases were offset by reductions in professional fees. As a percent of total revenue, general and administrative expenses decreased to 10.8% for the nine months ended September 30, 2025 from 12.0% for the nine months ended September 30, 2024.

***Other (Expenses) Income*** 

*Interest Expense* 

Interest expense remained flat at $3.6 million for the nine months ended September 30, 2025 and 2024.

*Interest and Dividend Income*

Interest and dividend income decreased by $1.7 million, or 20%, from $8.3 million for the nine months ended September 30, 2024 to $6.6 million for the nine months ended September 30, 2025. The decrease was primarily due to lower investment in the money market account as the Company funds ongoing operations.

*Other Expenses* 

Other expenses increased by $18.8 million, from $1.1 million for the nine months ended September 30, 2024 to $19.9 million for the nine months ended September 30, 2025. The increase was primarily attributable to a $16.4 million loss on debt extinguishment recognized in connection with the partial repurchase of 2027 Notes, and to a lesser extent to the increases in foreign exchange losses and non-income based taxes.

*Income from Unconsolidated Joint Venture* 

Income from unconsolidated joint venture remained flat at $0.5 million for the nine months ended September 30, 2025 and 2024.

*Additional Segment Considerations* 

Segment Adjusted EBITDA from our U.S. reportable segment for the nine months ended September 30, 2025 and 2024 was $20.2 million and $(3.8) million, respectively. Segment Adjusted EBITDA from our International reportable segment for the nine months ended September 30, 2025 and 2024 was $(10.1) million and $(6.9) million, respectively.

Refer to Note 5, *Segments* as we changed our measure of segment profit or loss in 2024 to Segment Adjusted EBITDA and recast prior-year data.

------

[<u>**Table of Contents**</u>](#toc_page)

**Liquidity and Capital Resources** 

***General*** 

We have financed our operations primarily through sales of our equity securities and borrowings under our convertible notes. As of September 30, 2025, our cash and cash equivalents and marketable securities totaled $224.5 million. We believe our existing cash and cash equivalents and marketable securities will be sufficient to support our working capital and capital expenditure requirements for at least the next twelve months. We believe we will meet our longer-term expected future cash requirements primarily from a combination of cash flow from operating activities and available cash and cash equivalents and marketable securities. We may also engage in equity or debt financings to secure additional funds. Our future capital requirements will depend on many factors, including our revenue growth rate, receivable and payable cycles, the timing and extent of investments in product development, sales and marketing, operations and support and general and administrative expenses.

Our capital expenditures consist primarily of internal-use software costs, manufacturing equipment, computers and peripheral equipment, furniture and fixtures and leasehold improvements and patents.

***Convertible Notes due 2030***

In June 2025, we issued $250.0 million aggregate principal amount of 2030 Notes pursuant to an indenture dated June 12, 2025, including the exercise in full of the initial purchasers' option to purchase up to an additional $25.0 million principal amount of the 2030 Notes. The 2030 Notes were sold in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2030 Notes were $241.4 million, net of debt issuance costs. The debt issuance costs are amortized to interest expense using the effective interest rate method.

The 2030 Notes are general unsecured obligations and bear regular interest at 0.75% per annum, payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2025. The 2030 Notes will mature on June 15, 2030 unless earlier repurchased, redeemed, or converted in accordance with their terms prior to such date.

The 2030 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 21.2495 shares of Class A common stock per $1,000 principal amount of 2030 Notes, which is equivalent to an initial conversion price of approximately $47.06 per share of our Class A common stock. The conversion rate is subject to customary adjustments for certain events as described in the indenture governing the 2030 Notes. In addition, following certain corporate events that occur prior to the maturity date of the 2030 Notes or if we deliver a notice of redemption in respect of the 2030 Notes, we will, under certain circumstances, increase the conversion rate of the 2030 Notes for a holder who elects to convert its 2030 Notes in connection with such a corporate event or convert its 2030 Notes called (or deemed called) for redemption in connection with such notice of redemption, as the case may be.

We may redeem for cash all or any portion of the 2030 Notes, at our option, on or after June 20, 2028 if the last reported sale price of our Class A common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the 2030 Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date.

Holders of the 2030 Notes may convert all or a portion of their 2030 Notes at their option prior to the close of business on the business day immediately preceding March 15, 2030, in multiples of $1,000 principal amounts, only under the following circumstances:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during any calendar quarter commencing after the calendar quarter ending on September 30, 2025 (and only during such calendar quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2030 Notes on each such trading day;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during the five business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of the 2030 Notes for each day of such ten consecutive trading day period was less than 98% of the product of the last reported sale price of our Class A common stock and the applicable conversion rate of the 2030 Notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on a notice of redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date, in which case we may be required to increase the conversion rate for the 2030 Notes so surrendered for conversion in connection with such redemption notice; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on the occurrence of specified corporate events.

On or after March 15, 2030, the 2030 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

------

[<u>**Table of Contents**</u>](#toc_page)

In the event of a fundamental change (as defined in the indenture governing the 2030 Notes), subject to certain conditions and limited exceptions, holders of the 2030 Notes may require us to repurchase for cash all or a portion of the 2030 Notes at a price equal to 100% of the principal amount of the 2030 Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date.

We accounted for the issuance of the 2030 Notes as a single liability measured at its amortized cost, as no embedded features require bifurcation and recognition as derivatives.

As of September 30, 2025, the 2030 Notes have a carrying value of approximately $241.9 million with an effective annual interest rate of 1.4%.

***Convertible Notes due 2027***

In February 2022, we issued $287.5 million aggregate principal amount of 2027 Notes pursuant to an indenture dated February 4, 2022. The 2027 Notes were issued in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The net proceeds from the issuance of the 2027 Notes were $278.2 million, net of debt issuance costs. The debt issuance costs are amortized to interest expense using the effective interest rate method.

The 2027 Notes are unsecured obligations and bear regular interest at 1% per annum, payable on February 1 and August 1 of each year. The 2027 Notes will mature on February 1, 2027 unless repurchased, redeemed, or converted in accordance with their terms prior to such date.

The 2027 Notes are convertible into cash, shares of our Class A common stock, or a combination of cash and shares of our Class A common stock, at our election, at an initial conversion rate of 17.8213 shares of Class A common stock per $1,000 principal amount of 2027 Notes, which is equivalent to an initial conversion price of approximately $56.11 per share of our Class A common stock. The conversion rate is subject to customary adjustments for certain events as described in the indenture governing the 2027 Notes. In addition, following certain corporate events that occur prior to the maturity date of the 2027 Notes or if we deliver a notice of redemption in respect of the 2027 Notes, we will, under certain circumstances, increase the conversion rate of the 2027 Notes for a holder who elects to convert its 2027 Notes in connection with such a corporate event or convert its 2027 Notes called (or deemed called) for redemption in connection with such notice of redemption, as the case may be.

We may redeem for cash all or any portion of the 2027 Notes, at our option, on or after February 5, 2025 if the last reported sale price of our Class A common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the 2027 Notes to be redeemed, plus accrued and unpaid interest or additional interest, if any.

Holders of the 2027 Notes may convert all or a portion of their 2027 Notes at their option prior to November 1, 2026, in multiples of $1,000 principal amounts, only under the following circumstances:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during any calendar quarter commencing after the calendar quarter ending on June 30, 2022 (and only during such quarter), if the last reported sale price of our Class A common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the applicable conversion price of the 2027 Notes on each such trading day;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•during the five-business day period after any ten consecutive trading day period in which the trading price per $1,000 principal amount of the 2027 Notes for each day of that ten consecutive trading day period was less than 98% of the product of the last reported sale price of our Class A common stock and the applicable conversion rate of the 2027 Notes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on a notice of redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, in which case we may be required to increase the conversion rate for the 2027 Notes so surrendered for conversion in connection with such redemption notice; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•on the occurrence of specified corporate events.

On or after November 1, 2026, the 2027 Notes are convertible at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

In the event of a fundamental change (as defined in the indenture governing the 2027 Notes), subject to certain conditions and limited exceptions, holders of the 2027 Notes may require us to repurchase all or a portion of the 2027 Notes at a price equal to 100% of the principal amount of 2027 Notes, plus accrued and unpaid interest.

We accounted for the issuance of the 2027 Notes as a single liability measured at its amortized cost, as no embedded features require bifurcation and recognition as derivatives.

We may, from time to time, repurchase our convertible senior notes using cash on hand, either on the open market or in privately negotiated transactions.

------

[<u>**Table of Contents**</u>](#toc_page)

***Partial Repurchase of 2027 Notes*** 

We used a portion of the net proceeds from the issuance of the 2030 Notes to repurchase approximately $201.7 million in aggregate principal amount of outstanding 2027 Notes. The total cash paid in connection with this repurchase was approximately $216.7 million, which included approximately $0.7 million to pay the accrued interest through the settlement date and an approximate $14.3 million premium. The repurchase resulted in a $16.4 million loss on debt extinguishment, which included the write-off of $2.1 million of deferred costs related to the 2027 Notes. The loss on debt extinguishment was recorded within Other expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

Following this partial repurchase, approximately $85.8 million aggregate principal amount of the 2027 Notes remain outstanding on our Condensed Consolidated Balance Sheet. The original terms and conditions continue to apply to the remaining notes, and the unamortized debt discount and issuance costs related to these notes will continue to be deferred and accreted.

As of September 30, 2025, the 2027 Notes have a carrying value of approximately $85.1 million with an effective annual interest rate of 1.6%.

***Capped Call Transactions***

In connection with the issuance of 2030 Notes, we entered into capped call transactions (the "Capped Calls") with respect to its Class A common shares with certain financial institutions. The Capped Calls are expected to reduce the potential dilution to our Class A common stock upon any conversion of the 2030 Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted 2030 Notes, as the case may be, with such reduction and/or offset subject to a cap based on a cap price initially equal to $63.35 per share and which is subject to certain adjustments under the terms of the Capped Calls.

We used approximately $17.5 million of the net proceeds from the 2030 Notes to pay the cost of the Capped Calls. These instruments are classified as equity and recorded as a reduction of additional paid-in capital in the Condensed Consolidated Statements of Changes in Stockholders' Equity. The Capped Call are not accounted for as derivatives and will not be remeasured; they will remain in stockholders' equity until expiration or settlement.

***Purchase of Treasury Stock*** 

In conjunction with the 2030 Notes issuance, we purchased 220,994 shares of our Class A common stock in privately negotiated transactions at an average price of $36.20 per share on June 9, 2025. The $8.1 million of treasury stock repurchase costs was funded using a portion of the proceeds of the 2030 Notes and was recorded as a reduction to stockholders' equity in the Condensed Consolidated Statements of Changes in Stockholders' Equity.

***U.S. Government***

A portion of our revenues and cash flow are derived from the U.S. government or through subcontractors to the U.S. government. During the quarter ended September 30, 2025, we did not experience delays in receiving payments from U.S. government agencies or subcontractors. However, the U.S. government began a shutdown on October 1, 2025. While none of our contracts or subcontracts have been impacted as a result to date; an extended government shutdown could result in a delay or suspension of funding for our U.S. government contracts and subcontracts and disrupt our cash flows and possibly delay new contracts from being awarded.

***Cash Flows*** 

The following table presents a summary of our cash flows from operating, investing, and financing activities for the nine months ended September 30, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|  | **2025** | **2024** |
|  | **(in thousands)** | **(in thousands)** |
| Net cash provided by (used in) operating activities | $1674 | $(24469) |
| Net cash used in investing activities | $(5982) | $(14734) |
| Net cash provided by financing activities | $2506 | $3215 |

---

***Operating Activities*** 

For the nine months ended September 30, 2025, net cash provided by operating activities was $1.7 million, primarily due to a net loss of $(53.1) million adjusted for non-cash charges of $63.0 million and a net $(8.2) million adjustment from changes in operating assets and liabilities. The non-cash charges primarily relate to stock-based compensation of $26.0 million, a loss on debt extinguishment of $16.4 million, depreciation and amortization of $13.7 million and a $3.4 million reduction to our right-of-use lease assets. The net decrease in operating assets and liabilities is primarily driven by the changes in accounts receivable of $23.4 million due to increased sales and a reduction in lease liabilities of $5.2 million, partially offset by changes in accounts payable and accrued cost of revenue of $10.7 million due to the timing of payments and growth, changes in other accrued expenses of $9.1 million and changes in contract liabilities of $3.2 million.

------

[<u>**Table of Contents**</u>](#toc_page)

For the nine months ended September 30, 2024, net cash used in operating activities was $24.5 million, primarily due to a net loss of $(40.5) million adjusted for non-cash charges of $36.5 million and a net $(20.5) million adjustment from changes in operating assets and liabilities. The non-cash charges primarily relate to stock-based compensation of $21.1 million, depreciation and amortization of $9.6 million, and a $3.3 million of reduction to our right-of-use lease assets. The net decrease in operating assets and liabilities is primarily driven by changes in accounts payable of $18.3 million due to the timing of payments, accounts receivable of $8.3 million due to increased sales and reductions in lease liabilities of $5.1 million, partially offset by changes in accrued expenses of $6.8 million and other assets of $4.4 million.

***Investing Activities*** 

For the nine months ended September 30, 2025, net cash used in investing activities was $6.0 million, primarily due to the purchase of property and equipment (which includes the internal-use software development costs) of $19.9 million and the purchase of marketable securities of $6.6 million offset by the sale of marketable securities of $20.5 million.

For the nine months ended September 30, 2024, net cash used in investing activities was $14.7 million, primarily due to the purchase of marketable securities $16.3 million and purchase of property and equipment (which includes the internal-use software development costs) of $13.6 million offset by the sale of marketable securities of $15.0 million.

***Financing Activities*** 

For the nine months ended September 30, 2025, net cash provided by financing activities was $2.5 million, primarily resulting from $241.4 million in net proceeds from the issuance of the 2030 Notes (net of issuance costs) and approximately $2.7 million from the exercise of stock options largely offset by outflows of $216.0 million to repurchase a portion of the 2027 Notes, approximately $17.5 million to purchase capped calls, and approximately $8.1 million to purchase treasury stock.

For the nine months ended September 30, 2024, net cash provided by financing activities was $3.2 million, relating to proceeds from the exercise of stock options.

**Critical Accounting Estimates**

Our condensed consolidated financial statements and accompanying notes have been prepared in accordance with GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Actual results may differ from these estimates. To the extent that there are material differences between these estimates and our actual results, our future financial statements will be affected. For additional information about our critical accounting policies and estimates, see the disclosure included in our Annual Report on Form 10-K for the year ended December 31, 2024 as well as Note 2, *Basis of Presentation and Summary of Significant Accounting Policies* in the notes to the condensed consolidated financial statements included in Part I, Item 1, of this Quarterly Report on Form 10-Q. There have been no material changes to our critical accounting policies and accounting estimates as compared to those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.

**Recent Accounting Pronouncements** 

For a description of our recently adopted accounting pronouncements and recently issued accounting standards not yet adopted, see Note 2, *Basis of Presentation and Summary of Significant Accounting Policies* in the notes to the condensed consolidated financial statements included in Part I, Item 1, of this Quarterly Report on Form 10-Q.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

We are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of exposure to potential changes in interest rates. We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure.

***Foreign Currency Exchange Risk*** 

Our U.S. revenue and costs are principally denominated in U.S. dollars and are not subject to foreign currency exchange risk. Our International operating segment generates revenue outside of the United States that is denominated in currencies other than the U.S. dollar. Our results of operations are impacted by changes in exchange rates. Outside the U.S., our International operations generated approximately 16% of our revenues for the nine months ended September 30, 2025, of which the majority was generated in Euros. If the average exchange rate of Euros changed unfavorably by 10%, our revenues for the nine months ended September 30, 2025 would have decreased by 1.3%. During the nine months ended September 30, 2025, our revenues were slightly impacted as the average exchange rate experienced modest fluctuations during the nine-month periods ending September 30, 2025 and September 30, 2024.

------

[<u>**Table of Contents**</u>](#toc_page)

***Inflation Risk*** 

We do not believe that inflation has had a material effect on our business, results of operations, or financial condition. If our costs were to become subject to significant inflationary pressures such as those caused by geopolitical tensions, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, results of operations and financial condition.

**Item 4. Controls and Procedures.**

***Evaluation of Disclosure Controls and Procedures***

We maintain "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2025. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of September 30, 2025.

***Changes in Internal Control over Financial Reporting***

There were no changes to our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

***Inherent Limitations on Effectiveness of Controls***

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

------

[<u>**Table of Contents**</u>](#toc_page)

**PART II—OTHER INFORMATION**

**Item 1. Legal Proceedings.**

From time to time, we are involved in various claims and legal actions that arise in the ordinary course of business. We are not a party to any legal proceedings, that individually or in the aggregate, are reasonably expected to have a material adverse effect on our consolidated results of operations, financial condition or cash flows. However, the results of these matters cannot be predicted with certainty, and an unfavorable resolution of one or more matters could have a material adverse effect on our consolidated results of operations, financial condition or cash flows.

For the period ended September 30, 2025, there were no material legal proceedings brought against us nor were there any material developments to any ongoing legal proceedings which constituted reportable events.

**Item 1A. Risk Factors.**

Investing in our Class A common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 31, 2024 under Part I, Item 1A, "Risk Factors," together with all of the other information in this Quarterly Report on Form 10-Q, including the sections titled "Management's Discussion and Analysis of Financial Condition and Results of Operations" and our condensed consolidated financial statements and related notes, before making a decision to invest in our Class A common stock. Our business, financial condition, results of operations, or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, financial condition, results of operations, and prospects could be adversely affected. In that event, the market price of our Class A common stock could decline, and you could lose part or all of your investment.

Other than as set forth below, there have been no material changes to our risk factors as previously disclosed in Item 1A. contained in Part I of our Annual Report on Form 10-K for the year ended December 31, 2024.

***Changes in U.S. and international trade policies could adversely impact our business, results of operations and financial condition.***

The recent announcements of substantial new tariffs and other restrictive trade policies have created a dynamic and unpredictable trade landscape, which may adversely impact our business. Current or future tariffs or other restrictive trade measures may raise the cost of raw materials, components or finished goods. We derive the majority of our revenue from the sale of parts and assemblies to our customers on our marketplace. Our business is therefore dependent upon the availability and price of raw materials, tools and components for assembly in various countries around the world. To the extent that significant tariffs, sanctions or similar restrictions are placed on certain goods imported into the United States or tariffs and similar measures, including retaliatory measures, are imposed by foreign governments, we could also face significant challenges in maintaining our cost-effectiveness, and we and our network of suppliers may be required to raise prices, thereby making our marketplace less attractive to buyers. To the extent suppliers increase their costs and we are unable to sufficiently pass such price increases on to our customers, or if the level of demand for the products and services we offer decreases as a result of any price increases, we may not be able to achieve or maintain profitability or otherwise maintain our historical margins. Our suppliers, and we as a result, may experience supply chain disruptions as a result of increased costs and uncertainty, including risks to the long-term viability of such suppliers, which may impact our ability to meet customer demand or cause reputational harm if we are unable to deliver products on expected timelines or if any price increases are poorly received by customers. In addition, many of our customers operate businesses that may be impacted by trade policies, which may result in decreased demand on our marketplace or extended sales cycles as customers assess the impact of evolving trade policies on their operations and face increased costs or decreased revenue due to tariffs and trade restrictions. As a result of the foregoing factors, our business, financial condition and results of operations could be materially and adversely affected.

Trade disputes, trade restrictions, tariffs and other political tensions between the U.S. and other countries may also exacerbate unfavorable macroeconomic conditions including inflationary pressures, foreign exchange volatility, financial market instability, and economic recessions or downturns, which may also negatively impact customer demand for products on our marketplace, delay purchases or renewals, limit expansion opportunities with customers, limit our access to capital, or otherwise negatively impact our business and operations. Ongoing tariff, trade restrictions and macroeconomic uncertainty has and may continue to contribute to volatility in the price of our Class A common stock.

The complexity of announced or future tariffs may also increase the risk that we or our customers or suppliers may be subject to civil or criminal enforcement actions in the U.S. or foreign jurisdictions related to compliance with trade regulations. In addition, retaliatory trade policies or anti-U.S. sentiment in certain regions whether driven by trade tensions, political disagreements, or regulatory concerns may make customers, governments and investors more hesitant to engage with, purchase from or invest in U.S. firms. This may lead to increased preference for local competitors, changes to government procurement policies, heightened regulatory scrutiny, decreased intellectual property protections, delays in regulatory approvals or other retaliatory regulatory non-tariff policies, which may result in heightened international legal and operational risks and difficulties in attracting and retaining non-U.S.

------

[<u>**Table of Contents**</u>](#toc_page)

customers, suppliers, employees, partners and investors. Further, international suppliers may elect not to continue engaging us, limiting our sourcing options and increasing our dependency on domestic suppliers.

While we continue to monitor trade developments, the ultimate impact of these risks remains uncertain and any prolonged economic downturn, escalation in trade tensions, or deterioration in international perception of U.S.-based companies could materially and adversely affect our business, results of operations, financial condition and prospects. In addition, tariffs and other trade developments have and may continue to heighten the risks related to the other risk factors described in our Annual Report for the fiscal year ended December 31, 2024.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

Not applicable.

**Item 3. Defaults Upon Senior Securities.**

Not applicable.

**Item 4. Mine Safety Disclosures.**

Not applicable.

**Item 5. Other Information.**

**Securities Trading Plans of Directors and Executive Officers**

During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Securities and Exchange Act of 1934, as amended) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company's securities, as set forth in the table below.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Type of Trading Arrangement** | **Type of Trading Arrangement** | **Type of Trading Arrangement** | **Type of Trading Arrangement** | **Type of Trading Arrangement** | **Type of Trading Arrangement** | **Type of Trading Arrangement** | **Type of Trading Arrangement** |
| **Name and Position** | **Action** | **Adoption/Termination Date** | **Rule 10b5-1\*** | **Non-Rule 10b5-1\*\*** | **Total Shares of Class A Common Stock to be Sold** | **Total Shares of Class A Common Stock to be Purchased** | **Expiration Date** |
| Sanjeev Singh Sahni<br>President | Adopted | 8/7/2025 | X |  | 41421 |  | 10/1/2026 |
| Emily Rollins<br>Director | Adopted | 8/11/2025 | X |  | 3000 |  | 4/1/2026 |
| Subir Dutt<br>Chief Sales Officer | Adopted | 8/18/2025 | X |  | 34851 |  | 7/1/2027 |
| Randy Altschuler<br>Chief Executive Officer | Adopted | 9/4/2025 | X |  | 65037 |  | 3/10/2027 |

---

\* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

\*\* "Non-Rule 10b5-1 trading arrangement" as defined in Item 408(c) of Regulation S-K under the Exchange Act.

------

[<u>**Table of Contents**</u>](#toc_page)

**Item 6. Exhibits.**

The documents listed in the Exhibit Index of this Quarterly Report on Form 10-Q are herein incorporated by reference or are filed with this Quarterly Report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).

---

| | |
|:---|:---|
| **Exhibit**<br>**Number** | **Description** |
| 3.1 | [<u>Amended and Restated Certificate of Incorporation of Xometry, Inc., (incorporated herein by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 001-40546), filed with the SEC on July 2, 2021).</u>](https://www.sec.gov/Archives/edgar/data/0001657573/000119312521207643/d184650dex31.htm) |
| 3.2 | [<u>Amended and Restated Bylaws of Xometry, Inc., (incorporated herein by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K (File No. 001-40546), filed with the SEC on July 2, 2021).</u>](https://www.sec.gov/Archives/edgar/data/0001657573/000119312521207643/d184650dex32.htm) |
| 31.1\* | [<u>Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</u>](xmtr-ex31_1.htm) |
| 31.2\* | [<u>Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</u>](xmtr-ex31_2.htm) |
| 32.1\*\* | [<u>Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</u>](xmtr-ex32_1.htm) |
| 32.2\*\* | [<u>Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</u>](xmtr-ex32_2.htm) |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

\* Filed herewith.

\*\* These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

------

[<u>**Table of Contents**</u>](#toc_page)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on

its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | XOMETRY, INC. | XOMETRY, INC. |
| Date: November 4, 2025 | By: | /s/ Randolph Altschuler |
|  |  | **Randolph Altschuler** |
|  |  | **Chief Executive Officer and Director**<br>**(Principal Executive Officer)** |
| Date: November 4, 2025 | By: | /s/ James Miln |
|  |  | **James Miln** |
|  |  | **Chief Financial Officer**<br>**(Principal Financial and Accounting Officer)** |

---

------

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Randolph Altschuler, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Xometry, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 4, 2025 | By: | /s/ Randolph Altschuler |
|  |  | **Randolph Altschuler** |
|  |  | **Chief Executive Officer and Director** |
|  |  | **(Principal Executive Officer)** |

---

------

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO**

**RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, James Miln, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Xometry, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: November 4, 2025 | By: | /s/ James Miln |
|  |  | **James Miln** |
|  |  | **Chief Financial Officer** |
|  |  | **(Principal Financial and Accounting Officer)** |

---

------

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Xometry, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 4, 2025 | By: | /s/ Randolph Altschuler |
|  |  | **Randolph Altschuler** |
|  |  | **Chief Executive Officer and Director** |
|  |  | **(Principal Executive Officer)** |

---

------

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Xometry, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: November 4, 2025 | By: | /s/ James Miln |
|  |  | **James Miln** |
|  |  | **Chief Financial Officer** |
|  |  | **(Principal Financial and Accounting Officer)** |

---

------